Determinants for successful deployment of clinical prediction models : a design science research in the Dutch healthcare sector by Creemers, Stefanie
  
 
 
 
   Bachelor’s thesis 
   Master’s thesis 
   Licentiate’s thesis 
   Doctor’s thesis 
 
Subject International Master in  Management of IT (IMMIT) Date 01-06-2019 
Author Stefanie Creemers 
Student number 
FR: 17028952 
FI:  518508 
NL: 2000787 / 325951 
 
Number of pages 140 
Title Determinants for successful deployment of clinical prediction models 
Supervisors 
dr. E.A.M. Caron (Tilburg University) 
dr. P. Rousseau (IAE Aix-Marseille) 
prof. H. Salmela (Turku University) 
ir. S. van Rijn RE (BDO Nederland) 
 
Abstract 
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PREFACE 
'The time has come,' the Walrus said, 
To talk of many things: 
'Of shoes — and ships — and sealing-wax — 
Of cabbages — and kings — 
And why the sea is boiling hot — 
And whether pigs have wings.' 
– Lewis Carroll,  
The Walrus and the Carpenter 
from his book Through the Looking-Glass (1871) 
 
 
The time has come (again). For the second time I am able to let this poem exemplify the 
completion of a master’s degree. The past two years have been marked by an unforgetta-
ble experience in France, Finland and the Netherlands. With this thesis I complete the 
triple master program International Master in Management of IT (IMMIT) at IAE Aix-
Marseille Université, Turku University, and Tilburg University. 
 
I would like to thank all colleagues at BDO Audit & Assurance Nederland for the 
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cerest gratitude to everyone who has been so generous to dedicate his or her time to my 
thesis project. It would not have been possible to conduct this research without the in-
sights of the many professionals that I was able to interview.  
 
Furthermore, I would like to thank all fellow students and professors that were in-
volved in our cohort. Semesters in three different countries have given me an unprece-
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GLOSSARY 
Clinical decision 
support systems 
Applications that use data analysis to provide support to healthcare pro-
viders in decision-making in order to improve patient care. 
Clinical  
prediction model 
A predictive data mining algorithm that provides risk estimates for diag-
nosis or prognosis of a disease for an individual patient. 
Clinical  
prediction tool 
A clinical prediction model captured in a tool that can be used by health 
practitioners to support the diagnosis and prognosis of diseases. 
Continuation 
The stage after implementation, when all predetermined requirements 
have been met in accordance with the initial design and the software can 
be used. The focus is on daily activities, operations, and management 
surrounding the software that must ensure its success over the long-term. 
Data mining The process of discovering meaningful patterns in large datasets through computer algorithms. 
Data science 
The field of study that aims to extract meaningful insights from data by 
combining domain expertise, programming skills, and knowledge of sta-
tistics. 
Deployment The overarching term for the period starting from the actual implementa-tion until the daily continuation of the new software. 
Descriptive  
analytics 
Type of business analytics that looks that provides reporting analytics 
with visualizations, ad hoc reporting, and trend analysis of past events. 
Design science An information technology research methodology that concentrates on development and performance of artifacts 
Diagnostic  
analytics 
Type of business analytics that valuates why something happened by de-
tecting root causes of a problem in the data. 
Diagnosis The discovery and identification of a disease. 
Etiology The causes and origins of a disease. 
Implementation 
The stage where a project is materialized or realized, initiated when a 
project has been assessed as feasible. In terms of the project life cycle, 
implementation is part of the execution phase. 
Machine learning 
The use of algorithms and statistical models by computers to automati-
cally learn information and patterns from data, without explicit instruc-
tions. 
P4 medicine Predictive, preventive, personalized, and participatory medicine. 
Personalized 
medicine 
Individualized patient care; a move away from the ‘one size fits all’ ap-
proach to healthcare. 
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Predictive  
analytics 
Type of business analytics that generates prediction power from data in 
order to forecast future activity, behavior, or trends. 
Prescriptive  
analytics 
Type of business analytics that determines ways in which business pro-
cesses should evolve or be modified. 
Prognosis The expected development of a disease over time. 
Project  
management 
An approach to achieve specific project objectives in a finite timespan 
by applying certain processes, methods, skills, and experience.  
Project success A project is considered a success when objectives are achieved in ac-cordance with the acceptance criteria formulated at the start of a project. 
Time series  
forecasting 
A method to transform past values into future estimates based on ma-
chine learning techniques based on certain time series assumptions. 
 
 
 
  
1 INTRODUCTION 
We are at the forefront of the big data revolution in healthcare. The application of big 
data and predictive analytics has the promise to play a momentous role in our healthcare, 
as pointed out in academic literature (Belle et al., 2015; Groves et al., 2013; Chawla & 
Davis, 2013; Sun & Reddy, 2013). Slowly, hospitals are implementing and experimenting 
with predictive models. However, the practical side remains undiscovered and hospitals 
lack experience in the implementation and continuation of clinical prediction models. It 
seems as if the promised revolution is stuck in first gear. 
1.1 General research area 
As a subset of data science, predictive analytics revolves around creating empirical pre-
dictions and prediction power from extremely large datasets (Shmueli & Koppius, 2011). 
Techniques such as data mining, machine learning and statistical modeling are utilized 
for the development of advanced algorithms that can detect patterns in data. These pat-
terns are able to predict future outcomes and trends, ensuring an acceptable level of reli-
ability. Analysts use what-if scenarios and risk assessments to create forecasts for the 
unknown future.  
Predictive analytics hold advantageous effects on all kinds of business areas, such as 
supply chain management (Waller & Fawcett, 2013), manufacturing (Shin et al., 2014), 
and human resources (Fitz-enz & Mattox, 2014). However, the application in healthcare 
is most beneficial to us all, as humans. It allows us to detect diseases in earlier stages and 
improve the quality and accuracy of clinical decisions (Wang et al., 2018). Clinical pre-
diction models (CPMs) for specific medical domains are being further developed and 
improved every day. At the same time, hospitals are carefully considering the potential 
benefits for their specific departments, specializations, and services. The barriers for de-
ployment of predictive models consist partly of generic elements that apply to most types 
of organizations. On the other hand, some barriers are not generalizable; they are inherent 
to the identity of the healthcare sector. 
1.2 Problem indication 
The demand for good healthcare keeps rising. We live in an era in which population age-
ing is a serious matter. The percentage of people over 65 years old amplifies; a develop-
ment that directly touches our healthcare system. Moreover, increased economic prosper-
ity causes higher expectations from healthcare and its capabilities. Technological 
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developments enable healthcare innovation, but that does not mean we need less 
healthcare. Diseases that used to be fatal have turned into chronic diseases, with lifelong 
need of treatment and medicine. The same economic prosperity also causes an expanding 
number of diseases related to our lifestyle, such as diabetes or cardiovascular diseases. 
All these elements contribute to a staggering increase of healthcare costs in the coming 
years. The Dutch Rijksinstituut voor Volksgezondheid en Milieu estimates that healthcare 
expenditure in the Netherlands will rise to 174 billion euros by 2040 (RIVM, 2018). That 
is a doubling of healthcare costs compared to 2015. However, the real problem that ac-
companies this future outlook resides in the huge lack of health professionals. Currently, 
the Uitvoeringsinstituut Werknemersverzekeringen (UWV, 2018) already expects an em-
ployee deficit in the Dutch healthcare system of hundreds of thousands the coming years. 
In other words, the demand for healthcare keeps growing, but the number of professionals 
to deliver the supply cannot keep up. Therefore, it is time to take advantage of other re-
sources. That is where data science and predictive modeling comes in. By utilizing the 
power of data science, it is possible to optimize the activities of health professionals and 
to transform available health data into value that can support clinical decision making. 
At this point in time, research is required in order to learn which challenges arise when 
predictive models are utilized in healthcare organizations. Whereas publications on CPMs 
are multiplying and news articles about pilot programs are spreading, there is a lack of 
academic research on the practicalities around actual application of the models. Hospitals 
are eager to explore the hyped theme of big data analytics in healthcare, but struggle to 
find actionable knowledge. Incomplete understanding on how the generated medical pre-
dictions should be integrated in practice, has increased the risk of technological backlash. 
According to Manlhiot (2018), the risk of backlash is a consequence of the new wave of 
overhyped expectations of predictive analytics in the medical field.  Indeed, healthcare in 
particular shows astronomical expectations with regards to the capabilities of predictive 
models. Together with the general insufficiency of required technological infrastructure 
in most medical settings, a serious need for a pragmatic deployment strategy resides. This 
thesis aims to bridge the gap between theoretical research and the actualities of CPMs.  
1.3 Motivation 
A more hands-on approach towards predictive models in healthcare is required for suc-
cessful deployment. The goal of this thesis is to gather actionable knowledge for hospitals 
and to provide a supportive framework in the follow up of technological opportunities 
that arise. Bridging the gap between theory and practice is essential in avoiding a potential 
tech backlash. The direct customers of this research are (academic) hospitals that 
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proactively engage in clinical prediction model solutions and encounter stagnation in its 
deployment.  
Firstly, this research is provoked by my personal motivations. As a data scientist, the 
immense opportunities that reside in complex healthcare data spark my fascination and 
galvanize me into action. Prediction models that can benefit clinical accuracy specifically 
take my interest.  
Secondly, the scientific relevance of this topic makes a contribution to the information 
management field by presenting a different type of investigation into predictive analytics 
in healthcare. Rather than the development of a CPM or the assessment of its potential, 
this thesis goes a step further in the process and investigates the deployment challenges 
of an actual tool in hospitals. Figure 1 shows the position of this research topic in literature 
(step 4). It is time that we move from discovery, development and analysis of CPMs to-
wards practical assessments (Dorajoo & Chan, 2017; Khalilia et al., 2015). First cross-
sectional, but in the future also longitudinal. A thoughtful set of best practices for deploy-
ment is needed to guide the rise of healthcare predictive analytics (Amarasingham, 2014). 
 
Figure 1 Position in literature based on factor time 
Thirdly, this research provides practical contribution to society in various ways. 
Healthcare organizations in different regions of the Netherlands are currently figuring out 
how to create value from predictive models. By conducting qualitative research in various 
health organizations, the experiences, opinions, and knowledge of these diffused groups 
are connected. This thesis serves as a binding force to unify the efforts of multiple inno-
vative health organizations nationwide. Furthermore, the outcomes of this study can im-
prove CPM usability and hence users’ daily activities. Identification of successful factors 
for deployment implies that pain points can be overcome, and that usage of CPMs can be 
simplified and streamlined. On the side of the patient, whose personal data is inserted into 
the predictive model, the outcomes of this study aid in improving the quality of their care 
and hence their well-being. Figure 2 shows that successful deployment of CPMs is a me-
diating variable between activities of healthcare professionals and the well-being of pa-
tients. On the side of the organization, the outcomes of this research can bestow better 
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preparations for deployment of these new models and tools. Identification of critical suc-
cess factors (CSFs) allows hospitals to anticipate deployment efficiently and effectively. 
 
Figure 2 Practical contribution of research as mediating variable 
Fourthly, as this thesis is effectuated in parallel with a graduate internship at BDO, the 
relevance for the IT audit healthcare team is shortly discussed. The technological play-
ground of hospitals is changing and new innovations are being introduced. Undoubtedly, 
more and more hospitals will make use of predictive analytics over the course of time. 
The use of data-driven solutions implies increased caution with regards to patient privacy 
and data security, and the need to keep an eye on changes in the IT processes as the 
controlling requirements might shift in the future. In general, it is useful for BDO to 
closely follow these technological developments and to dispose of in-depth knowledge. 
The advisory line of service within BDO already focuses on the power of data analytics 
and counsels many organizations in their data analytics strategy. The outcomes of this 
study can be a worthwhile addition to the advisory portfolio in the healthcare sector. 
1.4 Problem statement and research questions 
Whereas the promises of business analytics in healthcare are clear; the executive practi-
calities are not. Mapping the factors that have a hand in implementation and continuation 
(i.e. deployment) improves execution of these models and hence improves diagnostic and 
prognostic healthcare for patients. The problem statement at the heart of this research is: 
 
“How to design a successful deployment strategy  
for clinical prediction models in hospitals?” 
 
In order to answer this problem statement, various research questions are formulated. 
The research questions (RQ) are each connected to different parts of the study and thus 
investigated using different methods. RQ1 is answered based on a thorough literature 
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review. RQ2 and RQ3 are answered by a requirements collection and multiple expert 
interviews. RQ4 and RQ5 are answered by combining the results from the literature re-
view, requirements collection, and expert interviews. RQ6 aims to test the designed arti-
fact by applying it to a case study through a gap analysis. The research questions are 
stated in Table 1. 
Table 1 Research questions 
RQ1 What are the factors for successful deployment of BI&A  according to existing literature? Chapter 4 
RQ2 What deployment factors of CPMs in hospitals are identified  by health professionals? Chapter 5.1 
RQ3 What artifact can be designed to successfully deploy CPMs  in hospitals? Chapter 5.1.4 
RQ4 What are the CSFs in a deployment plan for CPMs in hospitals as identified by health professionals? Chapter 5.2 
RQ5 What other factors have a hand in the successful deployment of CPMs in hospitals according to health professionals? Chapter 5.3 
RQ6 How to test the designed deployment strategy in a case study? Chapter 6 
 
The ultimate product of this research is the design of a deployment artifact with an 
accompanied strategy for deployment success. 
1.5 Research design 
The nature of this study is exploratory and qualitative, as the focus is on collecting new 
insights in a flexible manner whilst considering all potential aspects of the problem state-
ment. The method of the research is design science. This method aims to design new 
artifacts in order to complement social capabilities with human competency (Hevner et 
al., 2010). In this thesis, the problem context of CPM deployment in hospitals is unraveled 
by the design and validation of an artifact.  
The problem statement is partitioned into multiple research questions. Firstly, a liter-
ature review is conducted to collect secondary data on the implementation and continua-
tion factors for BI&A projects, and more specifically for prediction models (chapter 4). 
The outcomes of the literature review function as the base to the conceptual model. Sec-
ondly, in order to validate the literature review, requirements collection interviews are 
conducted (section 5.1). The artifact is constructed, serving as the backbone for this thesis 
(subsection 5.1.4). After that, multiple expert interviews are conducted in order to validate 
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the developed artifact (section 5.2) and to acquire additional insights (section 5.3). Lastly, 
a case study at a hospital in the Netherlands is conducted to test the developed artifact in 
a real situation through a gap analysis (chapter 6). Finally, the recommendations ema-
nated from the artifact lead to the design of a successful deployment strategy for clinical 
prediction models. Figure 3 shows a graphical representation of the research design steps. 
 
Figure 3 Research design 
1.6 Research scope 
This research is explicitly limited in scope by various borders. Firstly, in the field of busi-
ness analytics, this research focuses on big data analytics with sufficient volume, variety, 
velocity, and veracity. Moreover, the research concentrates on predictive modelling based 
on machine learning and statistical techniques. Within healthcare these predictive models 
are aimed to support medical diagnosis and prognosis, and are thus called clinical predic-
tion models (CPMs). Secondly, of the broad healthcare sector only general and academic 
hospitals are included. Thirdly, the interview target group are experts in the following 
four areas: clinical specialists, data scientists, IT experts, and health software companies. 
This creates a mix between CPM users, developers, functional managers, and commercial 
vendors. Figure 4 provides a graphical representation of the research scope. 
 
Figure 4 Scope of the research 
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1.7 Outline 
This thesis is structured as follows. Chapter 2 provides an extensive literature back-
ground, discussing the topics of  predictive analytics, project management and their ap-
plications in the healthcare sector. Chapter 3 explains the methodology behind the re-
search. Chapter 4  is a literature review, in which the various factors for successful de-
ployment of business analytics models are summarized. Chapter 5 consists of the results 
from the requirements collection interviews and the expert interviews. The artifact is con-
structed and insights are collected on the deployment factors and related topics. Chapter 
6 is dedicated to a case study in a Dutch hospital were the artifact is operationally tested 
through a gap analysis. Chapter 7 presents the conclusions, recommendations, limitations 
and future directions of this research.   
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2 LITERATURE BACKGROUND 
In this chapter, a literature background is presented, in order to place the thesis topic and 
problem statement in context. The chapter makes use of the funnel technique, starting 
with generalities and gradually narrowing down to the focus of the thesis (Figure 5). In 
section 2.1, the field of Business Intelligence and Analytics (BI&A) is explained includ-
ing various related concepts, industry methodology standards, and the topic of predictive 
analytics. In section 2.2, the field of predictive analytics is specified for clinical purposes. 
The uniqueness of BI&A in healthcare is discussed, as well as various applications of 
data analytics for healthcare. In section 2.3, existing project management (PM) strategies 
are demonstrated. First general information technology (IT) implementation plans are 
highlighted, later the section zooms in on standards specifically for data mining projects. 
Section 2.4 takes the topics of clinical prediction models (CPMs) and the deployment 
phase in project management together. 
 
Figure 5 Structure of chapter 2 
2.1 Business Intelligence & Analytics 
From insurance companies to sport analysts to streaming platforms to hospitals: the use 
of big data analytics for future predictions is the subject of attention. By dint of big data, 
faster computing, cheaper storage and advanced algorithms, we are now able to forecast 
the future.  
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2.1.1 Concepts of BI&A 
A definition of BI&A is “the techniques, technologies, systems, practices, methodologies, 
and applications that analyze critical business data to help an enterprise better understand 
its business and market and make timely business decisions” (Chen et al., 2012, p.1166). 
As such, BI&A is the overarching umbrella of various types of data-driven technologies.  
All BI&A efforts are based on the availability of big data. Without the presence of 
large volumes of data, BI&A would not exist. There is a difference between business 
intelligence (BI) and business analytics (BA). BI helps organizations to make intelligent 
decision for current operations. Data is monitored, collected and reported for interpreta-
tion and quickly communicated in dashboards to implement the findings. BA aims to 
understand the trends behind the data, using statistical algorithms to allow for future out-
looks. Rather than figuring out what happened when to who, BA attempts to figure out 
what will happen. The methods are not reports or dashboards, but different types of ana-
lytics (descriptive, diagnostic, predictive, and prescriptive), data mining, statistical anal-
ysis, or simulations. The academic branch of data science is mainly concentrating on BA. 
Predictive analytics (PA) is one subset of business analytics that uses data to forecast the 
future. Clinical predictive modeling is the application of predictive analytics in the 
healthcare sector. Various characteristics related to the disease, patient, or treatment are 
combined to predict a diagnostic or prognostic outcome. In order to do that, certain tech-
niques are used, such as data mining and machine learning. 
Data mining is carried out by an individual who uses computer programs with machine 
learning capabilities to find patterns in data. Data mining techniques are for example clus-
ter analysis, classification, regression trees, and neural networks. These techniques can 
be either unsupervised or supervised. With unsupervised data mining the focus is on dis-
covery since the answers are unknown, whereas supervised data mining does have the 
correct answers. Using machine learning, the computer is able to study algorithms to ex-
tract information automatically. It is called ‘machine learning’ because the machine, i.e. 
the computer, is able to learn from experience and simultaneously improve its perfor-
mance. These procedures are often derived or inspired by classical statistics.  
The term artificial intelligence (AI) is also often used in the BI&A context. AI aims to 
program a computer in such a way that it can behave as an intelligent agent. In other 
words, it allows the performance of certain tasks by systems that normally require some 
type of human intelligence. AI is based on machine learning, and even more advanced, 
on deep learning. Deep learning is a subfield of machine learning that makes use of algo-
rithms based on artificial neural networks which imitate the functionality of the human 
brain. Figure 6 provides a graphical overview of the explained concepts of BI&A. 
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Figure 6 Concepts of BI&A visualized 
2.1.2 Big data 
Nearly every step you take is recorded by some device that collects data. Bundling all this 
isolated data into one big pile results in what is called ‘big data’. Big data makes it pos-
sible for managers to measure, and thus know, fundamentally more about what is going 
on in their business (McAfee et al., 2012). This results in increased performance due to 
the ability to improve decision-making. As McAfee et al. (2012, p.4) state: “you can’t 
manage what you don’t measure”.  
According to Davenport (2012), three points differentiate organizations that utilize 
traditional data analysis from organizations that capitalize on big data. Firstly, organiza-
tions using big data follow continuous flows and processes, rather than events that oc-
curred in the past. Secondly, they employ data scientists, not data analysts. This implies 
the mastering of a variety of skills, ranging from programming to business. Solely ana-
lytical capabilities do not suffice. Thirdly, the analytics function receives prominent at-
tention and is placed into the core business operations.  
    As depicted in Figure 7, three characteristics describe what big data entails: volume, 
variety, and velocity (Zikopoulos et al., 2012). First, the massive volumes of data can be 
overwhelming to organizations. In 2012, we no longer speak about terabytes but about 
petabytes. In 2018, research group IDC predicts that by 2025 we will be creating 163 
zettabytes (or 163 trillion gigabytes) of data worldwide (Reinsel et al., 2018). Second, the 
variety of data adds a factor of complexity to big data. Rather than the traditional rela-
tional data, big data also contains raw, semi-structured and unstructured entries. This im-
plies a fundamental shift in the requirements of data analysis. Third, the velocity of big 
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data considers how quickly data is generated, stored and retrieved. Big data analytics 
needs to take into account the volume and variety of data that is still in motion. 
Over the past years, the V-model has been extended with many extra characteristics 
starting with the letter ‘v’. Veracity refers to the amount of data reliability and trust given 
its source, and variety corresponds to the monetary merits that stem from big data analyt-
ics (Assunção et al., 2015). Uddin & Gupta (2014) even propose 7 V’s that capture big 
data, adding ‘visible’ and ‘visual’. More V’s are wandering around with potential to be 
added to the V-model (volatility? vulnerability? validity? variability? viability? vitality?), 
but arguably the most important one overall is value. Without deriving value from big 
data, the other V’s are unimportant. Value is the holy grail of big data and what all organ-
izations are ultimately looking for. 
 
Figure 7 Big data: volume, variety, velocity (Zikopoulos et al., 2012) 
2.1.3 Business analytics 
The overarching term of ‘business analytics’ entails all technologies, applications, and 
skills connected to the continuous and iterative investigation of big data for business in-
sights (Beller & Barnett, 2009). According to Gartner (2016), business analytics can be 
descriptive, diagnostic, predictive, or prescriptive in nature: 
• Descriptive analytics, or reporting analytics, wants to find out ‘what happened’ 
through visualization, ad hoc reporting, and trend analysis of past events. 
• Diagnostic analytics evaluates ‘why it happened’. Root causes of a problem are 
detected in the data. 
• Predictive analytics uses statistical and data mining techniques to predict poten-
tial future outcomes. It asks the question of ‘what is likely to happen’. 
• Prescriptive analytics goes beyond the description, explanation and prediction of 
data, and wants to know ‘what should be done about it’. Courses of action are 
suggested that lead to optimization of future business processes.  
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As depicted in Figure 8, the four analytics capabilities are divided on the continuum 
between human-centered and machine-centered. Moreover, the further in the continuum, 
the closer analytics come to actual decision making and action. PA is fairly close to ma-
chine-centered decision making, but is restricted to just prediction of future events. PA 
helps organizations to understand the future, but does not give advice on possible out-
comes. 
 
Figure 8 The four business analytics capabilities (Gartner, 2016) 
2.1.4 Data mining 
Data mining can be explained as the process of detecting meaningful patterns in large 
datasets (Larose, 2015). Machine learning algorithms are applied to go through the col-
lected data and find these patterns.  With data mining, multiple types of tasks can be per-
formed: description, estimation, classification, clustering, association, and; prediction. 
Predictive analytics (PA) is a technology that allows us to predict the future behavior of 
individuals by learning from the past (Siegel, 2013). It distinguishes itself from other 
types of analytics by the way it approaches data: predictive models are induced by data-
driven algorithms rather than by assumptions of the analyst. Moreover, data mining can 
only become predictive when in combination with domain knowledge. Powerful induc-
tion of algorithms automates the process of finding meaningful patterns.  
2.1.5 Benefits of predictive analytics  
When implemented successfully, PA can generate considerable improvements in deci-
sion-making, efficiency and return on investment (Abbott, 2014). Especially when PA 
projects are incorporated into the business strategy, significant benefits can be realized 
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(Siegel, 2013). Examples of such benefits are: optimized productivity, cost efficiency, 
error detection, waste elimination, lower process cycle time, resource optimization, im-
proved sales forecasts, dynamic pricing, and much more (Attaran & Attaran, 2019). In a 
way, PA has the power to improve an array of different operational and organizational 
activities in all kinds of sectors. 
Wang et al. (2018) use a multidimensional benefit framework to categorize the ad-
vantages of 26 big data cases in healthcare. The five dimensions are: IT infrastructure, 
operational, managerial, strategic, and organizational. The various dimensions and ac-
companied benefits are depicted in Table 2.  
Table 2 Multidimensional benefit framework of PA (Wang et al., 2018) 
Dimension Description Examples 
IT infrastructure  
benefits 
Sharable and reusable IT 
resources that provide a founda-
tion for present and future busi-
ness applications 
 Building business flexibility for 
current and future changes 
 IT cost reduction 
 Increased IT infrastructure ca-
pability 
Operational  
benefits 
The benefits obtained from the 
improvement of operational activ-
ities 
 Cost reduction 
 Cycle time reduction 
 Productivity improvement 
 Quality improvement 
 Customer service improvement 
Managerial  
benefits 
Business management 
activities which involve allocation 
and control of the firms' re-
sources, monitoring of operations 
and support of business strategic 
decisions 
 Better resource management 
 Improved decision making and 
planning 
 Performance improvement  
Strategic  
benefits 
The benefits obtained from strate-
gic activities which involve long-
range planning regarding high-
level decisions 
 Support for business growth 
 Support for business alliance 
 Building for business innova-
tions 
 Building cost leadership 
 Product differentiation 
Organizational  
benefits 
When the use of an enterprise sys-
tem benefits an organization in 
terms of focus, cohesion, learning, 
and execution of strategies. 
 Changing work patterns 
 Facilitating organizational 
learning 
 Empowerment 
 Building common vision 
25 
 
2.2 Predictive analytics in healthcare 
The healthcare industry and big data analytics go hand in hand. Available healthcare in-
formation is stored in all types of sources, such as electronic health records (EHR), patient 
portals, clinical decision support systems, research and development, Internet of Things 
(IoT) devices, social media, and genetic databases (Raghupathi & Raghupathi, 2014). The 
application of advanced analytics to patient profiles for predictive modeling is a terrific 
opportunity. 
2.2.1 BI&A in healthcare 
The umbrella term BI&A includes many different data-driven techniques (subsection 
2.1.1). In healthcare, BI is related to the conduct of business of a healthcare organization. 
For example, optimization of the number of available beds or the logistics behind availa-
ble devices for surgery. It is about the processes surrounding the actual care; the business 
improvements that increase efficiency, effectiveness and quality of care. BA goes to the 
core of clinical healthcare. Rather than using historical data to improve current operations, 
it uses data mining to create algorithms for machine learning. EHRs are one of the major 
sources of clinical data science, including laboratory values (tabular data), doctor’s notes 
(semi-structured or free text), medical imaging (audiovisual data), and computerized or-
der entry systems (Kubben et al., 2019). For example, BA in healthcare can use MRI 
scans to predict the progression of dementia (Korolev et al., 2016) or predict the chance 
of developing genetic colorectal cancer based on health record (Drost et al., 2018).  
2.2.2 Uniqueness of data mining in healthcare 
Data mining in healthcare needs to tackle some issues inherent to the industry. The safety 
critical context of medicine demands the inclusion of ethics and the cost of prediction 
(Bellazzi & Zupan, 2008). Compared to other industries, the healthcare industry has a few 
unique features when it comes to data mining. Cios & Moore (2002) identify four princi-
pal points that are unique to medical data, and that influence (predictive) data mining 
opportunities. These points are: 
• Heterogeneity of medical data; 
• Ethical, legal, and social issues; 
• Statistical philosophy; 
• Special status of medicine. 
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The healthcare industry produces monstrous amounts of data every day. Medical im-
aging, patient interviews, laboratory data, and practitioner's notes are all potential inputs 
for data mining algorithms.  Since medical data is coming from a variety of sources, their 
structure and quality are not always comparable. Moreover, a canonical form of elements 
in biomedicine is often not present. For one type of diagnosis, numerous distinct expres-
sions exist that are medically equivalent. Unlike other disciplines, this poses a challenge 
to the coding of medical data. 
The discussion of data ownership of medical data is ongoing (Telenti et al., 2018). Do 
individuals own their own medical data? Or are the clinicians that collect the data the 
owners? Can hospitals actually use this data? The ethical and legal considerations behind 
this are complicated−more complicated than data that is not medical. Hospitals’ fear for 
lawsuits is a logic consequence of this confusion.  
Healthcare is primarily about patient care and curing people. Only secondarily it serves 
as a resource to research. The majority of the data collection is possible only because it 
benefits the patient. Statistical philosophy requires repeatable experiments with predeter-
mined parameters. Experiments cannot be interrupted, but in reality this is complicated 
to align with the well-being of patients.  
A unique feature of medicine is its special status in science and society. Healthcare is 
a necessity rather than an optional convenience, and it touches every single one of us in 
the weighty matter of life and death. Medicine is a safety critical context that requires 
supportive explanations in every decision (Fox & Das, 2000). Expectations of healthcare 
are high; we expect that sick people can get better. At the same time, society is highly 
critical about what goes on in healthcare. When medical care regrettably fails, responses 
are vengeful. This makes the development and deployment of data mining techniques a 
unique endeavor. Compared to other industries, data mining in healthcare could be the 
most rewarding, but only if all its particular challenges are taken into consideration.  
2.2.3 Etiology, diagnosis, prognosis and treatment 
In medicine, there is a significant difference between terminologies for disease acknowl-
edgement of which the average person is not aware. For correct communication between 
data scientists and healthcare professionals on the objectives, context, and consequences 
of clinical prediction models, it is critical to have an identical understanding of the termi-
nology. Especially data scientists must invest in this knowledge, as it is not part of their 
standard academic or professional curriculum.  Medicine recognizes four types of disease 
evaluation: 
• Etiology: the causes and origins of a disease; 
• Diagnosis: the discovery and identification of a disease; 
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• Prognosis: the expected development of a disease over time; 
• Treatment: the medical attention given to combat a disease. 
Data analysis is mostly applied to the diagnosis and prognosis types of healthcare (Van 
Kuijk et al., 2018). A predictive model aiming at diagnosis uses data to identify the dis-
ease at the moment of prediction and to give it the right name. A predictive model aiming 
at prognosis uses data to predict the expected outcome of a disease. 
2.2.4 Time series forecasting 
Time series forecasting is a method to transform past values into future estimates based 
on mathematical or statistical models that include certain assumptions in terms of time 
patterns (Bui et al., 2018). In a clinical setting, the distinct features of time series fore-
casting can be applied with great impact. Short-term time series forecasting is potentially 
valuable for emergency care, whereas long-term forecasting can assess the health condi-
tions years after discharge based on treatment effects and risks. In healthcare, it is im-
portant that the collected data points are measured at “uniformly spaced time intervals” 
(Soyiri & Reidpath, 2013). Time series forecasting provides the statistical settings that 
are required to describe health data that seems to be random and fluctuating and to project 
the data series into the future (Chatfield, 2004; Shumway & Stoffer, 2006). Various con-
ditions need to be taken into consideration when tackling time series data (Soyiri & 
Reidpath, 2013): 
• Trend: the long-term variation in a time series without any irregular, systematic 
fluctuations; 
• Cyclicality: the extent to which data points are influenced by general patterns; 
• Seasonality: the extent to which data points are influenced by general patterns 
related to annual events with a yearly trend line; 
• Randomness: unexpected anomalies of existing or expected trends; 
• Lag: the lapse of time prior to the manifestation of an effect; 
• Stationarity: the level of variation in statistical properties (e.g. mean, variance, 
autocorrelation) over time. Most forecasting methods assume stationarity of the 
data, therefore non-stationary data is often mathematically transformed.  
2.2.5 Personalized medicine and its challenges 
Personal clinical, genetic, genomic, and environmental information is the base of person-
alized medicine (Ginsburg & Huntington, 2009). It is an integrated, coordinated, and ev-
idence-based approach that aims to individualize healthcare. La Thangue & Kerr (2011) 
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describe the application of personalized medicine in the oncology field. As a result of 
progress in biomarker technology, the molecular and genetic composition of tumors are 
reflected and aligned with the most appropriate treatment. As such, the population-based 
‘one drug fits all’ treatment model has shifted towards a more personalized approach in 
which predictive biomarkers provide diagnostic and prognostic assistance.  
A myriad of obstacles must be overcome before personalized medicine can be em-
ployed in real life (Hamburg & Collins, 2010; Soroushmehr & Najarian, 2016). Patients 
need to be confident in the reliability of the clinical tests. Understanding patients’ needs 
and readiness for adoption are similarly important as the actual development of the tech-
nologies (Issa et al., 2009). Another critical step for achieving personalized medicine is 
the integration of data into validated information that can be used directly for diagnosis, 
prognosis, or treatment (Castaneda et al., 2015). Generally, big data analytics poses some 
inherent challenges, such as missing data, imprecise data, and heterogenous data. The 
employment of data analytics in healthcare adds certain issues to this list, such as patient 
privacy, data ownership, confidentiality, and repeatability of biological data. Addition-
ally, inadequate knowledge about the human system is a challenge to personalized medi-
cine. Limited access to the brain leads to incomplete understanding of the biological net-
works and thus treatment outcomes. More investment is required towards the understand-
ing of the human body through computational models. 
2.2.6 ‘P4’ medicine  
Sagner et al. (2017) propose a ‘P4 Health Continuum’ as a framework to harness technol-
ogy and evidence-based interventions. This new way to address medicine is predictive, 
preventive, personalized and participatory; together labeled as ‘P4’. Pioneered fifteen 
years ago by Hood (2004), the ‘P4’ approach was back then expected to naturally lead to 
personalized medicine that would revolutionize healthcare. Over the past decade, the ma-
jor elements of the ‘P4’ vision have indeed been largely adopted (Flores et al., 2013). The 
‘P4 Health Continuum’ framework focuses on chronic disease management and aims to 
reduce the burden and societal impact of chronic illnesses. Other recent research high-
lights the application of ‘P4’ medicine in myopenia (Morley & Anker, 2017), obstructive 
sleep apnea (Pack, 2016), cystic fibrosis (Corvol et al., 2016), asthma (Canonica et al., 
2018), and many more diseases.  
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2.2.7 Clinical decision support systems 
Clinical decision support systems (CDSS) use machine learning to learn from past events 
by recognizing patterns in clinical data (Berner, 2007). Through electronic systems, 
CDSS can communicate the predictions coming from the mathematical algorithm through 
user-friendly interfaces at the front-end (Castaneda et al., 2015). Moja et al. (2015) state 
that the use of CDSS in healthcare will increase in the near future due to several factors: 
the quality of medical care receives growing concerns, there is a continuous call for mean-
ingful use of health IT, and clinicians are increasingly familiar with the use of advanced 
technologies.  
Various studies aim to provide recommendations on how to make predictive modelling 
and CDSS more effective (Ash et al., 2012; Lobach et al., 2012; McGinn et al, 2012; 
Moxey et al., 2010; Osheroff et al., 2012). For example by means of governance, training, 
logistics, or design features. A study by Roshanov et al. (2011) found that CDSS have the 
power to modify practitioner test-ordering behavior. For optimization of the use of clini-
cal prediction models in practice, it was found that system design, user interface, local 
context, and implementation strategy are potentially important factors. In terms of design, 
a CDSS tool can be considered directive when therapeutic recommendations are given, 
and assistive when simply the model predictions are presented. The lack of direct com-
parison between a directive and an assistive prediction format in a single population, may 
lead to bias or generalizability issues (Kappen, 2015). 
Kawamoto et al. (2005) argue that healthcare organizations should implement CDSS 
with automatic decision support as part of the user’s workflow, providing actionable rec-
ommendations that are delivered in time. Less crucial but still desirable features of the 
CDSS are periodic performance feedback, request documentation of why a recommenda-
tion was not followed, and sharing decision support results with patients. Although the 
foundation of this quindecinnial research continues to be relevant, requirements of suc-
cessful CDSS nowadays are more extensive. The Healthcare Information and Manage-
ment Systems Society (HIMSS) is an American non-profit organization that aims to im-
prove the quality, safety, and cost effectiveness of healthcare through IT. In their books 
on clinical decision support systems, they provide authoritative guidance on the imple-
mentation of CDSS (Osheroff et al., 2012). HIMMS presents the book as a guidebook for 
successful deployment of CDSS, with tips and tricks on how to overcome various chal-
lenges. The most common reasons that CDSS are not yet deployed are the challenge to 
convert data into a clinically relevant model, the complexity to integrate the model into 
the clinical workflow, and the ethical and legal repercussions of computerized recom-
mendations (Belard et al., 2017).  
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2.2.8 Existing clinical prediction models 
Scientists have published the development of various CPMs. Each model specifically tar-
gets one disease type and is the result of specialized expertise of a clinical area. In this 
subsection, a few existing CPMs are mentioned. 
Dawes et al. (2017) use supervised machine learning to predict patient survival and 
mechanisms of right ventricular failure due to high blood pressure in the arteries to the 
lungs. They conclude that their algorithms indeed allow for more accurate predictions of 
patient outcome and that machine learning based on cardiac magnetic resonance imaging 
(MRI) could guide diagnostics. Desautels et al. (2016) investigated a prediction method 
for sepsis, a serious infection caused by the immune system, which they call InSight. 
Based on a minimal set of variables from EHR data, InSight is found to be an effective 
tool for sepsis onset prediction. A study using routine clinical data focused on the risk 
prediction of cardiovascular diseases, such as stroke and heart failure (Weng et al., 2017). 
They conclude that the established algorithm was able to identify patients eligible for 
preventive treatment, while avoiding unnecessary remedies for other patients. Another 
risk prediction model designed by Thottakkara et al. (2016) concentrates on postoperative 
complications. Meretoja et al. (2017), propose a validated prediction model and online 
risk calculator that identifies patients at high risk for developing enduring pain after breast 
cancer surgery. In the mental health domain, Walsh et al. (2017) applied machine learning 
to EHRs in order to predict future suicide attempts and found it to be a more accurate 
method than traditional statistical methods. No clear consensus on the best methodology 
for building clinical prediction models exists, therefore Lee et al. (2016) and Steyerberg 
& Vergouwe (2014)  summarized several steps for development and validation.  
Besides the academic development of CPMs, the commercial developments by large 
corporations are also noteworthy. IBM consider themselves as one of the pioneers with 
regards to AI software for medicine (IBM, 2019). For instance, the IBM Watson for On-
cology technology uses medical records to identify potential treatment options ranked by 
degree of confidence. This tool supports the oncologist in the decision-making of appro-
priate treatments for a specific diagnosis and prognosis. Other big players, such as 
Google, Apple and Amazon also gain ground in clinical prediction research. Google has 
made most progress in the diagnosis of diabetic eye disease and breast cancer detection 
(Google, 2019). Figure 9 shows an example of tumor detection by Google. An algorithm 
is able to autonomously evaluate biopsy imaging of lymph nodes and predict whether 
tissue patch is benign or a tumor. 
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Figure 9 Close-up picture of a lymph node biopsy. Google’s algorithm can accu-
rately identify the tumor region, without confusion by the macrophages.1 
2.2.9 Deceleration of the predictive analytics revolution 
With a myriad of research on predictive analytics in medicine and the development of 
specialized prediction models, it is only intuitive to wonder why they are not yet widely 
implemented. What causes the deceleration of the promised PA revolution in healthcare?  
Poor data quality and incompatible datasets has been a limitation ever since the begin-
ning of machine learning (Cortes et al., 1995; Dhindsa et al., 2018; Obermeyer & Eman-
uel, 2016). EHR databases require prudent curation and processing before they are usable. 
The digitalization and integration of EHRs and platforms comes with some constraints: 
confidentiality of genomic data, technological security breaches, and the logistics be-
tween and amongst healthcare providers and researchers (Castaneda et al., 2015). The 
solution according to Dhindsa et al. (2018) resides in the adoption of data standards that 
guarantee data quality and compatibility between institutions. For the advancement of 
patient care with PA, it is essential that new data policies are established by joint effort 
of clinicians, data scientists, patients, and society. Moreover, data fragmentation is a ma-
jor issue in clinical data science. Traverso et al. (2018) point out four restraining barriers 
to big data exchange: 
• Administrative barriers: the additional efforts required from the hospital facility, 
leading to increased personnel costs; 
• Ethical barriers: various data privacy concerns and national legislations regard-
ing privacy and confidentiality; 
• Political barriers: data sharing resistance, no joint effort by the community; 
• Technical barriers: scarce interoperability across healthcare organizations. 
                                              
1 Source: https://ai.google/healthcare/ 
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The technical barriers directly call attention to another problem: the lack of highly 
skilled data experts. This talent shortage will only grow; the Quant Crunch report (Mar-
kow et al., 2017) indicates an expected rise in demand for data scientists of 28% by 2020.  
Furthermore, the concerns with regards to privacy are a restriction for the (predictive) 
analytics revolution (Patil & Seshadri, 2014; Raghupathi & Raghupathi, 2014). Grover et 
al. (2013) proposes that in order to sustain the momentum, the collective mindset about 
sharing patient data must shift from “protect” towards “share, with protections”.  
According to Iniesta et al. (2016) the main challenge of applying CPMs in practice is 
the external validation of the models. Generalization to other populations can be a prob-
lem. The cross-trial study by Chekroud et al. (2016) externally validated their findings 
and conclude that for depression a machine learning model is able to forecast the treat-
ment efficacy of antidepressants. Most studies (Dawes et al., 2017; Desautels et al., 2016; 
Thottakkara et al., 2016; Weng et al., 2017) rely solely on internal cross-validation and 
are thus less likely to be generalizable to other populations and health systems.  
Another reason for the revolution slowdown is the hype around it. Since 2017, machine 
learning is exiting the ‘peak of inflated expectations’ in the hype cycle for emerging tech-
nologies (Figure 10). It is thus expected that now we will enter a ‘trough of disillusion-
ment’ in which interest fades and implementations fail to deliver. Stronger appreciation 
of the capabilities and limitations of PA might soften the crash into this next stage (Chen 
& Asch, 2017). Hopefully it is then possible to move on as soon as possible towards the 
‘slope of enlightenment’ stage, in which data will improve our collective health by virtue 
of the predictive analytics revolution. 
 
Figure 10 Hype cycle for emerging technologies in 2017. Machine learning is exit-
ing the ‘peak of inflated expectations’ phase. (Gartner, 2017) 
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    Lastly, inconsiderate use of prediction results are a serious danger. An example is 
the model calculating risk of death of patients that arrived at the emergency room with a 
pneumonia (Caruana et al., 2015). This model predicts that patients with both a pneumo-
nia and asthma have a relatively favorable prognosis compared to patients with pneumo-
nia and no asthma. Thus, the model indicated that the former group could be sent home 
safely. This unintended consequence was due to the fact that the model did not take into 
account the aggressive treatment and hospital admission of patients with both pneumonia 
and asthma, which made it seem they had a relatively positive prognosis (Cabitza et al., 
2017). Hence, the scope of one ‘wrong’ model implemented in practice is considerably 
bigger than the scope of one ‘wrong’ assessment of a clinician. The possibility of predic-
tive models to disseminate misinformation and cause harm suggests the need for more 
oversight, especially in profit-driven markets (Shah et al., 2018) 
2.3 IT project management standards 
Numerous standards for IT project management help to make projects a success. A project 
follows a series of stages, in which different activities play the main role. Next to general 
approaches to IT project management, specific models exist for data mining projects in 
particular. In this section it becomes clear that the phase of deployment is an important 
step in the data mining project management standards.  
2.3.1 Project management methodologies  
Project management (PM) is an approach to achieve specific project objectives by apply-
ing certain processes, methods, skills, and experience (Larson & Gray, 2017). A project 
is considered a success when the objectives are achieved in accordance with the ac-
ceptance criteria, including constraints in scope, time, quality, and budget. This implies 
that project management follows a final deliverable in a finite timespan, rather than an 
ongoing management process. 
Over the years, various PM methodologies have been developed, tested, and utilized 
in practice. Some are specifically directed to software development. The waterfall meth-
odology was one of the first approaches developed by Royce in 1970. This sequential 
methodology is divided into discrete stages that must be entirely completed before mov-
ing onto another. The agile methodology was developed as a response to the shortcomings 
of the waterfall technique in complex projects. This approach is iterative with small, in-
cremental steps that are responsive to external changes. This makes it more flexible and 
adaptable, and hence better suited for projects which do not have a clear end point. It is 
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possible to choose a hybrid approach, combining waterfall and agile. Scrum is an ap-
proach that can be used in agile projects. It is fast-paced following short sprints and has 
a focus on self-organized and self-managing teams. Similar is Kanban, where collabora-
tive teams work on continuous delivery through workflow visualizations. 
Other PM methodologies are not specific to software development. Lean methodology 
promotes the flow of value while minimizing waste. The Six Sigma methodology focuses 
on quality improvements by reducing errors. The Critical Path Method categorizes all 
activities into a breakdown structure and maps durations and dependencies. The Critical 
Chain Project Management (CCPM) reuses this approach through the lens of resource 
management. The Integrated Project Management (IPM) methodology emphasizes shar-
ing and process standardization through the organization. Projects integration Sustainable 
Methods (PRiSM) focuses on minimization of harmful environmental impacts of a pro-
ject, extending beyond the end of a project to maximize sustainability. Projects IN Con-
trolled Environments (PRINCE2) is the official methodology of the United Kingdom 
government. Clearly defined stages and a lifecycle, measurable products and predefined 
responsibilities are part of it. The Project Management Life Cycle (PMLC) methodology 
divides a project into stages and builds an approach around that. The Project Management 
Institute (PMI) created the Project Management Body of Knowledge (PMBOK), which 
is more a set of standard terminology and guidelines rather than a methodology. It can be 
used to weigh in on the best practices for a project.  
2.3.2 Project process model for information systems 
The numerous PM methodologies, with each their specified practices, techniques, and 
procedures, generally share the notion of phases. Processes run across various phases 
which break down a project into more digestible parts and allows the tracking of deliver-
ables. An example of PM phases are: initiation, planning, execution, control, and closing. 
Cadle & Yeates (2004) propose a process model as a generic framework for information 
systems projects (Figure 11).  
 
Figure 11 Project process model (Cadle & Yeates, 2004) 
The model can be tailored according to the requirements of a specific project. The se-
quential nature of the activities implies a waterfall approach. However, various types of 
life cycles are allowed within the stages of the model, such as a phased delivery approach 
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or a spiral model. As in most methodologies, the process model shows a project divided 
into a number of stages from start to finish with clear deliverables. For the successful 
deployment of a data mining solution it is rudiment to acknowledge and follow a project 
process model such as the one illustrated in Figure 11.  
2.3.3 Implementation strategies for IT 
The implementation (or execution) phase revolves around putting the project plan into 
motion, and is hence the start of project deployment as defined in this thesis. Already 30 
years ago, the importance of implementation management for the maximization of bene-
fits from IT investments was stressed (Cooper & Zmud, 1990). The adoption of a com-
prehensive framework and examination of related constructs in a systematic manner can 
prescribe what issues should dominate in each of the IT implementation stages. 
Gottschalk (1999) created an IT strategy implementation matrix with a clear priority on 
elements in the implementation plan. Important factors are the description of responsibil-
ity of time, budget, intended benefits, and user involvement. When looking at the user 
perspective on change, a study by Joshi (1991) uses equity theory to describe resistance 
to change by information systems users. Users evaluate their net gain of a change, in this 
case a new IT-related implementation. The model provides a useful framework for man-
aging resistance to change during implementation from a behavioral perspective. The def-
inition of a clear and comprehensive IT implementation strategy is key in any type of IT 
implementation, in any type of organization.  
2.3.4 CRISP-DM 
Next to general PM methodologies, standards exist for the managing of data mining pro-
jects. For an industry-neutral, tool-neutral, and application-neutral approach towards data 
mining, the Cross-Industry Standard Process for Data Mining (CRISP-DM) was devel-
oped in the 1990s (Chapman et al., 2000). This freely available standard provides a com-
mon, structured method for the planning and executing of data mining techniques for 
strategic problems  (Larose, 2015). Praised for its powerful practicality, flexibility and 
usefulness, it is widely used in PM and academic research.  
The CRISP-DM declares six lifecycle phases of a data mining project (Figure 12). 
Critical to note is that the CRISP-DM is both adaptive and iterative in nature. That is, 
phases often depend on outcomes associated with previous phases, and lessons learned 
from the past serve as input for new projects.  
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Figure 12 Phases of CRISP-DM process (Chapman et al., 2000) 
The process starts with an understanding of the business and the problem definition in 
the Business Understanding phase. The importance of this phase is further highlighted in 
part 2.4.4. After data collection, the data quality is evaluated in the Data Understanding 
phase. Following are the labor-intensive Data Preparation phase and the Modeling phase. 
After the model settings are calibrated for an optimal result, the Evaluation phase comes 
to a decision regarding the use of the data mining results. Those results are carried out in 
the last step; the Deployment phase. Here, the discoveries of the data mining model are 
used in practice to improve parts of the business. The integration of these discoveries into 
use is exactly where the topic of this thesis is located. Although this phase is recognized 
in the CRISP-DM, there is no further instruction on the tactics for deployment. Detailed 
steps of the CRISP-DM process are provided in Table 3. 
Table 3 Detailed steps of the CRISP-DM process phases 
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2.3.5 CRISP-MED-DM 
Niaksu (2015) created an extension to the CRISP-DM specifically for the medical do-
main. The CRISP-MED-DM addresses the typical data mining issues portrayed in the 
healthcare sector in each of the steps of the framework. Those issues include the mining 
of non-static datasets, clinical information system interoperability, semantic data interop-
erability, ethical and social constraints, patient data privacy, and the active involvement 
of clinicians in the knowledge discovery process (Niaksu, 2015). The general tasks, ac-
tivities and associated deliverables of the extension all apply to phases 1-4. For the eval-
uation phases and the deployment phase, Niasku (2015) states that no significant changes 
are required. Part of the deployment phase is the ‘identification of possible problems’. 
Although this might not require a significant variation from the original CRISP-DM, it 
does need a more extensive and complete explanation of how exactly health organizations 
can do this. This thesis perfectly fills that gap. 
2.3.6 ASUM-DM  
The Analytics Solutions Unified Method for Data Mining (ASUM-DM) is a refined ver-
sion of the CRISP-DM process methodology created by IBM in 2015 (Haffar, 2015). 
New activities, templates, and guidelines were added in an attempt to compensate for the 
weaknesses of the old model (Angée, 2018). The ASUM-DM is described as a hybrid 
agile and traditional implementation approach that is enterprise-ready, scalable and user-
friendly (IBM Analytics, 2016). 
 
Figure 13 Phases of ASUM-DM process (IBM Analytics, 2016) 
Rather than six phases, the ASUM-DM has five phases in which each phase is over-
seen by a project management stream (Figure 13). The PM stream is a crucial component 
as it ensures coordination in communication and collaboration. The five phases are Ana-
lyze, Design, Configure & Build, Deploy, and Operate & Optimize. The main difference 
compared to CRISP-DM is that deployment and operation are separated and that new 
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facets, such as collaboration, compliance, security, and version control are added in those 
phases.  
CRISP-DM and by extension ASUM-DM are considered the most popular methodol-
ogies for data mining projects and thus for PA projects. Employing those frameworks 
avoids reinvention of the wheel and duplicate efforts by companies and researchers 
(Larose, 2015). 
2.3.7 Other data mining standards 
Next to the data mining standards described in the previous subsections, some other data 
mining methodologies are shortly presented.  
SEMMA stands for Sample, Explore, Modify, Model, and Assess. It is developed by 
SAS Institute as an alternative to CRISP-DM (Matignon & SAS Institute, 2007). 
SEMMA is different from CRISP-DM because it was developed specifically for the soft-
ware package Enterprise Miner. SAS describes it as a “logical organization of the func-
tional toolset of SAS Enterprise Miner for carrying out the core tasks of data mining” 
(Dean, 2014). Due to its focus on Enterprise Miner and on model development specifi-
cally, SEMMA follows a lighter approach towards the initial planning stages (business 
understanding and data understanding in the CRISP-DM). The deployment phase is en-
tirely removed. 
KDD stands for Knowledge Discovery in Databases and involves seven steps: data 
cleaning, data integration, data selection, data transformation, data mining, pattern eval-
uation, and knowledge representation (Fayyad et al., 1996). The overall goal is to extract 
knowledge from large databases.  In order to do so, patterns are evaluated and interpreted 
and transformed into new knowledge. The process of KDD is iterative, hence new data 
can be added, algorithms can be updated, and evaluation measures enhanced. Compared 
to CRISP-DM, KDD focuses more on the steps to execute data mining, rather than a 
description of a project management approach. 
2.4 Deployment challenges for predictive analytics in healthcare 
This section starts off with clarifying the concept of deployment. The deployment of IT 
in healthcare and the deployment of PA comes with some challenges. However, literature 
on deployment challenges for predictive models specific to the healthcare industry are 
scarce. In order to fill this literature gap, the role of business understanding in deployment 
and the concept of project ‘success’ is highlighted. 
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2.4.1 Deployment, implementation, and continuation 
The terms deployment, implementation, and continuation are used interchangeably in var-
ious external sources, but actually have a different meaning. It is important to elucidate 
the meaning of each term throughout this thesis. 
The ‘implementation’ stage entails the stage where a project is materialized or realized. 
Implementation is initiated when a project has been assessed as feasible (Bonnal et al., 
2002). In terms of the project life cycle, implementation is part of the execution phase. 
Since the project at hand is a CPM, it is a software implementation.  
The ‘continuation’ stage follows after the implementation stage. When the software is 
up and running and all predetermined requirements have been met in accordance with the 
initial design, the implementation phase is over. Now, it is about the daily activities, op-
erations, and management surrounding the software that must ensure its success over the 
long-term.  
The term of ‘deployment’ is used to describe “the action of bringing resources into 
effective action” (“deployment”, n.d.). Deployment of a project includes both implemen-
tation and continuation. Thus, it is the overarching term for the period starting from the 
actual implementation until the daily continuation of the new software. Figure 14 visual-
izes the relationship between the three concepts in the context of this thesis. 
 
Figure 14 Deployment, implementation, and continuation of a project 
2.4.2 IT deployment challenges in healthcare 
Successful deployment of new technologies in healthcare is complex, due to a range of 
interrelated organizational, technical and social factors (Cresswell & Sheikh, 2013). In-
troduction of new technologies in healthcare is a process that is dynamic and iterative in 
nature, rather than linear (Cresswell et al., 2010). For successful implementation it is nec-
essary to achieve a degree of alignment between the three factors (i.e. organizational, 
technical, social). In contrast, Cresswell & Sheikh (2013) conclude that such normative 
approach to success is not possible due to the complexity in the relationships between the 
dimensions. They do however recognize several crucial factors for IT implementation 
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and continuation in healthcare: user involvement, effective leadership, early demonstra-
ble benefits, training and support, and close fit with organizational processes, 
For a successful implementation of patient care information systems, several chal-
lenges might hamper the process (Berg, 2003). First, the transformational character af-
fects both the implementing organization and the implemented technology, as they trans-
form each other. Second, such a strategic process can only work if supported by manage-
ment and future users. This requires a top-down framework in which users are directed 
into a coherent steering force. Third, a careful balance is needed between proactively 
initiating organizational change through IT implementation, and drawing upon the tech-
nology as a change agent. In other words, healthcare organizations must find the balanc-
ing line between setting direction for change and simply drifting with the created current. 
Experimenting and mutual learning is more important than planning and control. How-
ever, this does not imply to lie in wait.  
A study by Greenhalgh et al. (2017) aims to create an evidence-based, pragmatic 
framework for the prediction and evaluation of success of technology-supported 
healthcare solutions. Those solutions are often promising, but fail because they are not 
adopted by individuals. Moreover, it is possible that those tech innovations fail to scale 
up locally, do not spread globally or have difficulties in endurance in the long-term. Their 
non-adoption, abandonment, scale-up, spread, and sustainability (NASSS) framework 
helps to identify technological innovations and their potential of large-scale, sustained 
adoption.  
Edmondson et al. (2001) investigated new technology deployment in hospitals. Spe-
cifically, they examined the relation between team learning and the way new routines are 
developed when existing routines are fortified by technology. Four process steps of suc-
cessful implementers were found: enrollment, preparation, trails, and reflection. This 
way, team motivation, psychological safety, and shared meaning were created. Technol-
ogy adoption and corresponding routines are thus influenced by the collective learning 
process of those directly responsible for the new implementation.   
Sharifi et al. (2013) focus on the e-health deployment challenges in medical organiza-
tions in Iran. A qualitative study compared general challenges gathered from existing 
literature to experts’ claims about Iranian medical organizations (Table 4). Although Iran 
engages in organizational e-health projects, it is a developing country in the Middle East, 
and hence not equivalent to Western countries. The authors recognize this in the challenge 
of privacy and security. Iran uses offline systems for e-health applications, which com-
pletely changes the privacy and security conditions. For all the other challenges, the au-
thors argue that Iranian cases are similar to that of other countries.  
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Table 4 General implementation challenges with examples and solutions in Iran 
(Sharifi et al., 2013) 
Deployment  
challenge Example  Solution  
Lack of standardization 
of e-health  
applications 
Multiple data formats Nationwide data standards 
Cost of systems Huge demand for hardware, software, and maintenance 
Centralized policies to mitigate 
overlap and duplicate costs 
Training costs Workshops Extension of e-health courses at medical universities 
Legal challenges Rejection of e-evidence in  judicial courts 
Legal agreement between  
judiciary and government 
Privacy and security Required to take systems  offline 
Appropriate firewalls and  
antivirus programs 
Implementation and  
acceptance time Management concerns 
Develop instructions and  
rewards 
Technical difficulties Server downtime Adopt business continuity  instructions 
Educational issues Different shifts of nurses Different learning sessions 
Resistance to change Medical staff does not want to follow new rules 
Education and awareness of  
potential benefits 
2.4.3 Barriers for deployment of predictive analytics 
PA tools often run into some obstacles during implementation, regardless of the industry. 
According to Abbott (2014), the four categories of most common reasons for failure are: 
obstacles in management, obstacles with data, obstacles with modeling, and obstacles in 
deployment.  For clarification purposes: Abbott (2014) identifies one category as ‘obsta-
cles in deployment’. The term ‘deployment’ is used in this context to refer to the period 
after implementation. This thesis uses another meaning of the term deployment. If the 
fourth category of Abbott (2014) would be named in a way consistent with this thesis, it 
would be referred to as ‘obstacles in continuation’. Table 5 gives an overview of the four 
categories and more detailed explanation. On a critical note: the overview by Abbott 
(2014) does not include obstacles that are related to the alignment of the initial problem 
and the abilities of the prediction model. 
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Table 5 Four categories of most common reasons for unsuccessful predictive 
models (Abbott, 2014) 
Obstacles in management 
• No top management support  
• Lack of resources 
• Lack of political will 
Obstacles with data • Data in wrong format 
• Leakage of (unknown) future data 
Obstacles with modeling • Overfitting 
• Overambition of the analyst 
Obstacles in deployment • Model not consistent with operational system 
• Data not in deployment format 
 
A research paper on behalf of IBM has also identified challenges encountered by or-
ganization in their PA implementation. Attaran & Attaran (2019) list these challenges, 
divided into technical and organizational type of challenges (Figure 15). Although the 
authors talk about ‘implementation’, most factors are also important for the continuation 
of PA projects. Furthermore, the authors warn for five strategic pitfalls of PA implemen-
tation (Attaran & Attaran, 2019). They argue that organizations should not approach PA 
in the same fashion as other BA projects due to the following five pitfalls: 
• Lack of planning. For a successful PA implementation, companies must think 
strategically upfront. A comprehensive planning and assessment of needs versus 
resources is required. 
• Data inaccessible for analysis. For the integration, unification, and standardiza-
tion of data coming from various sources, effective data management must be 
incorporated by PA tools.  
• Inexperience of users. Successful implementation requires thorough knowledge 
of the techniques behind the PA tool. If the skills and experience are not present 
in-house, a hired team of data experts can be the solution. 
• No clear responsibilities. Different roles within the organization should receive 
specific responsibilities. For example, data scientists should not be given the 
business responsibilities that actually belong to business managers.  
• Lack of focus. One business initiative should be the focal point at each point in 
time. It is easy to become distracted when too many indicators are tracked and 
traced at the same time. 
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Figure 15 Implementation challenges of PA (Attaran & Attaran, 2019) 
2.4.4 The importance of business understanding 
The numerous approaches to PM differ to a certain extent in the description and sequence 
of the stages. However, for data mining projects such as clinical prediction models, the 
recommended starting point is mostly the understanding of the business domain. As pro-
posed by Niaksu (2015) in the CRISP-MED-DM, a terminology more fit to the healthcare 
sector would be ‘problem understanding’, to avoid the business case approach in the clin-
ical application domain. This stage generally encompasses the development of project 
objectives both from a clinical and healthcare management perspective, the associated 
success criteria, and an evaluation of the required resources. Sharma & Osei-Bryson 
(2009) find in their research that this phase is often implemented ad hoc. They argue that 
the reason for this unstructured approach is the general lack of attention to the importance 
of this phase. This leads to inefficiencies in time and resource planning, or could even 
steer the project towards a direction other than intended.  
In the business understanding (BU) phase of CRISP-DM, the success factors of the 
project are supposed to be determined. That means that the BU phase pervades all other 
project phases. Menger et al. (2016) propose a CRISP-IDM method and find that domain 
understanding (BU phase) cannot be underestimated, as it forms the basis for data selec-
tion thereby directly influencing the successfulness of the project. It also is the first step 
in interacting with the local workforce. Involvement of healthcare professionals turned 
out very helpful in the deployment phase, especially in terms of practical support. Sharma 
& Osei-Bryson (2009) utilize the CRISP-DM model to create a framework that depicts 
the dependencies between phases (Figure 16). This is based on the observation that output 
from certain tasks may serve as the inputs to other tasks. In conclusion, the authors argue 
that the BU phase is pivotal to the success of a data mining project, since its choices and 
outcomes affect all other phases, including the deployment. The output of the BU phase 
produces a project plan for the deployment of the project.  
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Figure 16 The business understanding phase pervades and impacts all other phases 
of a data mining project (Sharma & Osei-Bryson, 2009) 
2.4.5 When is project deployment considered a success? 
The success or failure of a project is difficult to assess, since different people have differ-
ent definitions of success. Myers (1994) argues that the perception of stakeholders on 
project success determines when success is achieved. However, perceptions can be influ-
enced by unrealistic expectations (Szajna & Scamell, 1993). It is a human tendency to 
underestimate challenges and overestimate personal capabilities under conditions of un-
certainty (Kahneman et al., 1982). On the other hand, those responsible for a project may 
be positively biased, since success implies prolongation of the project (Wilson & 
Howcroft, 2002). It is impossible to assess success in a simplistic one-dimensional meas-
ure, since all projects are different and are measured on various dimensions (Wateridge, 
1998). Therefore, success is a multidimensional construct that varies per project.  
Thomas & Fernández (2008) found that three effective practices aid in reaching suc-
cess of IT projects: an agreed definition of success, consistent management, and the use 
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of results. Success in project management used to be based on constraints in time, cost, 
and performance as embodied in the Project Triangle. This model, whose origins are un-
clear, states that changes in one constraint directly demand changes in another constraint 
or else project quality will suffer. Kerzner (2009) states that nowadays project success is 
dependent on more than just these three constraints: 
• Within the allocated time period; 
• Within the budgeted cost; 
• At the proper performance or specification level; 
• With acceptance by the customer/user; 
• With minimum or mutually agreed upon scope changes; 
• Without disturbing the main work flow of the organization; 
• Without changing the corporate culture. 
 
Figure 17 The traditional project triangle extended and linked to CRISP-DM busi-
ness understanding phase 
The definition of success is directly linked to the BU phase, as discussed in the previ-
ous subsection. In this first phase, the objectives and goals are determined, which must 
be achieved in order to call the ultimate deployment a success. In conclusion, the very act 
of defining and measuring project success in the BU phase contributes to success itself. 
The deployment of a data mining project is considered a success when the predetermined, 
concrete objectives are met with a certain level of assurance. Whether this means tech-
nical performance, employee satisfaction, budget, time, or something else, is thus estab-
lished in the first phase of project management. Figure 17 shows the extended project 
triangle and the CRISP-DM BU phase at the base for the recognition of project success.   
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3 METHODOLOGY 
This chapter describes the methodology that is used for this research in detail. An over-
view of the research design is provided, as well as an explanation of design science. More-
over, the various data collection methods are highlighted.  
3.1 Research design 
The nature of this study is exploratory and qualitative, as the focus is on collecting new 
insights in a flexible manner whilst considering all potential aspects of the problem state-
ment. A problem is investigated that has not yet been clearly defined. Ultimately, the 
outcomes of this thesis intend to clarify the existing problem, but will not provide con-
clusive results. Again, the problem statement: 
 
“How to design a successful deployment strategy  
for clinical prediction models in hospitals?” 
 
Firstly, a literature review is conducted to collect secondary data on the implementa-
tion and continuation factors for BI&A tools and more specifically for CPMs. In order to 
validate the literature review, requirements collection interviews are conducted. Based on 
the outcomes, a deployment artifact is constructed, serving as the backbone for this thesis. 
After that, multiple expert interviews are conducted in order to validate the developed 
artifact. According to the outcomes of the requirements collection and expert interviews, 
the artifact is modified into the most accurate and complete representation of the context. 
Followed by these interviews and artifact modification is a case study at a hospital in the 
Netherlands. Here, the goal is to test the developed artifact in practice. Two sets of ques-
tionnaires are used to compare the baseline objectives in terms of deployment factors with 
the current status of the deployment factors. Finally, the recommendations emanated from 
the artifact lead to the design of a successful deployment strategy for clinical prediction 
models. Figure 18 visualizes the research design of this thesis project. 
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Figure 18 Research design 
3.2 Design science methodology 
Design science is “the design and investigation of artifacts in context” (Wieringa, 2014, 
p.3). Design science “creates and evaluates IT artifacts intended to solve identified or-
ganizational problems” (Hevner et al., 2004, p.77). By designing an artifact a problem 
context is identified and improved (Wieringa, 2014). Hence, the goal is the develop an 
artifact and improve its functional performance. In this thesis, the problem context of 
CPM deployment in hospitals is unraveled by the design and validation of a deployment 
artifact. In short: a model for successful deployment is created.  
The design science process revolves around six steps: problem identiﬁcation and mo-
tivation, deﬁnition of the objectives for a solution, design and development, demonstra-
tion, evaluation, and communication (Peffers et al., 2007). Figure 19 provides an over-
view of the six steps.  
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Figure 19 The design science process (Peffers et al., 2007) 
3.3 Data collection 
In order to create and validate a new conceptual model based on design science, this thesis 
uses a multi-method approach. By means of methodological triangulation it is possible to 
study a phenomenon using more than one method (Casey & Murphy, 2009; Risjord et al., 
2001). This thesis is a ‘within-method study’, meaning that more than one data collection 
procedure is utilized, but never in a mix of qualitative and quantitative (Bekhet & Zausz-
niewski, 2012). All data collection is primarily qualitative, with a combination of existing 
literature review, interviews and a final case study.  
3.3.1 Literature review 
The first part of the research consists of a theory development on the implementation and 
continuation of BI&A tools. Through an extensive literature review, a conceptual model 
is created. The appropriate literature is gathered through online libraries and databases, 
as well as hard copies from the university collection. In the quest for relevant papers, 
different search strategies have been used. Key words and concepts derived from the 
problem statement are combined, as well as relevant synonyms. For some searches, the 
periodic range has been limited to ensure only recent work is found. The reference list of 
appropriate papers is consulted to discover related papers that confirm, apply, improve, 
extend or correct findings. The literature review is utilized for the creation of the artifact. 
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3.3.2 Requirements collection 
In this step, the literature review overview (Appendix A) is presented to experts with the 
goal to validate the findings. The outcomes of the requirements collection are utilized for 
the conceptual model and the construction of the artifact. The factors as identified in the 
literature are considered, and possibly removed, altered, or new ones are added. Moreo-
ver, the categorization is reviewed and possibly altered as well. 
The requirements collection phase consists of four interviews. Respondents with dif-
ferent professional backgrounds were questioned in order to incorporate various point of 
views (Table 6). One expert provided input from a risk management perspective. This 
relatively distant perspective allows for a more broad, oversight outlook. Due to time 
constraints and limited access to relevant interviewees, a total of four people is considered 
as sufficient. The limitations with regards to this choice are discussed in chapter 7.3.  
Interviewees received a short explanation of the study. The first phase of the interview 
consists of an open discussion. In the second phase, interviewees are asked to give their 
opinion on each factor of the literature review. Semi-structured questions were prepared 
as back-up, but the interviews were mostly conducted in an unstructured fashion. The 
interview format can be found in Appendix B. 
Interviewees for the requirements collection were approached through online chan-
nels. Searches for news articles, organization websites, and LinkedIn descriptions were 
used to track down relevant experts. After a positive response to an introduction message, 
a physical meeting was planned. The ability to interact face-to-face contributes to the 
quality of the gathered information as the relationship with the interviewee is strength-
ened (Lavrakas, 2008). All interviews were conducted in Dutch. For interpretation by the 
international audience of this thesis, all interviews are transcribed into English. The tran-
scriptions are part of additional documentation that can be shared upon request. 
Table 6 Expert panel for requirements collection 
ID Point of view Functional description 
RC-01 Medical Head of clinical department  
RC-02 Medical/Data Applied data analytics in medicine 
RC-03 Data Clinical data scientist 
RC-04 Risk management Sr. manager IT risk assurance 
3.3.3 Expert interviews 
By  means of expert interviews, the created conceptual model is validated. In terms of 
design science, this model is referred to as the artifact. The completeness, correctness, 
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and applicability of the artifact is tested. Semi-structured interview questions are used in 
order to gather detailed and directed qualitative data (Sekaran, 2003). Moreover, the var-
ious factors are ranked by the experts based on their importance to success. A 6-point 
Likert-scale from “highest importance” to “absolutely no importance” is used to let the 
interviewee pick a level of criticality. However, since the approach is qualitative, the in-
terviewee is asked to explain their choice with extensive arguments. Hence, the Likert-
scale serves as a guiding tool to provide a qualitative opinion. This way, correct interpre-
tation of the expert opinions by the interviewer is guaranteed. The results of the Likert-
scale in combination with the explanations are used to determine the average level of 
importance to success for each of the factors. The goal is to ultimately identify CSFs. 
The expert interviews consist of a series of eight interviews. In these interviews experts 
from different function groups express their opinion. Table 7 provides an overview of the 
expert panel. The clinical medicine side is represented, as well as the data medicine side. 
Interviewees come from mix of hospitals and UMCs, and from health IT software com-
panies. The mix of these backgrounds creates an interesting blend of opinions. Since “the 
typical criteria regarding sample size are irrelevant” (Yin, 1994, p.50), there is no hard 
rule on the required number of participants. Rather, the sample size should be sufficiently 
large to ensure saturation, that is, to ensure no new significant findings are uncovered. 
Again, limitations in time and access are at play in the decision of the sample size.  
Interviewees for the expert interviews were approached through online channels. 
Searches for news articles, organization websites, and LinkedIn descriptions were used 
to track down relevant experts. After a positive response to an introduction email or mes-
sage, a physical meeting was planned to interview the expert face-to-face. The ability to 
interact face-to-face contributes to the quality of the gathered information as the relation-
ship with the interviewee is strengthened (Lavrakas, 2008). All interviews were con-
ducted in Dutch. For interpretation by the international audience of this thesis, all inter-
views are transcribed into English. The interview format and transcriptions are part of 
additional documentation that can be shared upon request. 
Table 7 Expert panel for expert interviews 
ID Functional description Organization type 
EI-01 Intensivist UMC 
EI-02 Data scientist  Health IT software services 
EI-03 Sales consultant Health IT software services 
EI-04 Data analyst Hospital 
EI-05 Data scientist Hospital 
EI-06 Head of Business Intelligence Hospital 
EI-07 Anesthesiologist  UMC 
EI-08 Head of Health Solutions Healthcare innovation 
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3.3.4 Case study 
After the validation of the theory development and artifact, a case study is conducted to 
apply the artifact in practice. How can this artifact actually be used in a real life situation? 
The method of case study is chosen to understand a real-world case and its contextual 
conditions that are pertinent to the artifact (Yin & Davis, 2007). By testing the artifact in 
practice, the aim is to assess its usability and utility. In other words, can the artifact be 
used in practice, for a useful purpose (Wieringa, 2014). 
The organization, or ‘the case’, is chosen because of the sufficient data access and the 
relevant activities related to applied predictive modeling. The case at hand is the Depart-
ment of Psychiatry at the UMC Utrecht, where a prediction model for violence risk is 
developed. More details of the case company are provided in chapter 6. 
The goal of the case study is to perform a gap analysis of the deployment factors. The 
initial goals at the start of the project are compared with the current situation. To what 
extent are the different deployment factors currently in place? A comparison between the 
two situations allows for a clear overview on the differences between the initial plans and 
the current situation. This directly links to the CRISP-DM model: the initial plans are 
developed in the BU phase. The current situation should preferably be tested at the de-
ployment phase. However, since the CPM at hand is not yet widely implemented, the 
current situation is at the evaluation phase of the CRISP-DM.  
Data is collected through questionnaires with a standardized set of questions about 
each deployment factor. The reason for this data collection instrument is the gathering of 
practical, fast results that can be easily compared. The baseline questionnaire is designed 
to ascertain the mission statement and strategic objectives of the project at the very start. 
Due to time limitations, it is not possible to hand out this questionnaire at the actual start 
of the project. Therefore, the respondent is asked to provide retrospective answers. The 
respondent plays a large role in the project team from the earliest days of the project. The 
second questionnaire is designed to ascertain to what extent the various factors are cur-
rently in place. Four respondents with various backgrounds have filled in this question-
naire. This results in a mix of perspectives including medicine, project management, and 
data. Table 8 provides an overview of the panel. The two interview formats are part of 
the additional documentation that can be shared upon request. 
The questionnaires contain a 5-point Likert scale ranging from ‘very little extent’-
‘very large extent’. At the end of the questionnaire, the option is given to provide textual 
explanation to the answers. The results of a Likert scale fall within the ordinal level of 
measurements, for which mean and standard deviation are inappropriate statistical calcu-
lations (Jamieson, 2004). Therefore, all outputs of the second questionnaires are treated 
as separate answers. Due to the restricted number of respondents, outputs are visualized 
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in radar charts. Traditional visualizations such as histograms, heatmaps, or Likert charts 
are not used, as their power increases with larger volumes of output. 
The end product of the gap analysis is an operational control between phase 1 (BU) 
and phase 6 (deployment) of the CRISP-DM model. In this case study, phase 6 is ex-
changed for phase 5 (evaluation), thereby creating an interim control of the original end 
product.  
Table 8 Expert panel for case study (second questionnaire) 
ID Functional description 
CS-01 Psychiatrist 
CS-02 Project team lead  
CS-03 Medical policy officer 
CS-04 Data manager 
3.3.5 Confidentiality 
The data collection involving interviews deals with confidentiality issues. Since various 
organizations are participating within the same industry, identities are not revealed in 
order to avoid publishing private company information. Interviewees are all anonymized 
with an individual code, as can be found in Table 6, 7 and 8. The interviewees were in-
formed about this confidentiality clause prior to the interview. The interviews will be 
audio-recorded for analysis purposes, but will not be made available to the public. More-
over, it was made clear that no internal documentation or patient data was needed for this 
research. 
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4 CONCEPTUAL MODEL: LITERATURE REVIEW 
In this chapter the two fields of PA in medicine and IT PM merge together in an effort to 
answer RQ1. Analysis of the literature on BI&A deployment resulted in the identification 
of five broad categories with multiple factors that are critical to success:  
• Management (section 4.1.); 
• People (section 4.2.); 
• Technology (section 4.3.); 
• Processes (section 4.4.); 
• Data (section 4.5.).  
The five categories are deducted from existing literature (Akter et al., 2016; Olszak & 
Ziemba, 2012; Yeoh & Koronios, 2010) and tailored to this research topic. The factors 
that make up these categories are often intertwined and interdependent. An overview of 
all factors with corresponding variable name, description, and literature is provided in 
Appendix A. For each factor, a decision is made on whether it is generic and thus appli-
cable to various sectors, or specific to the healthcare sector. The result is a comprehensive 
table that provides an overview of all deployment factors of CPMs. 
 
RQ1 What are the factors for successful deployment of BI&A  according to existing literature? Chapter 4 
4.1 Management 
The category ‘Management’ looks at success of deployment from the organizational di-
mension. Sponsorship and support of top management is widely acknowledged as crucial 
for success of any analytics tool (Akhavan & Salehi, 2013; Gao et al. 2015; Hawking & 
Sellitto, 2010; Popovič et al., 2018; Saltz & Shamshurin, 2016; Wamba et al., 2015). It is 
therefore a generic factor. Consistent support of top management allows for sufficient 
funding, skilled staff, and overall motivation of the team (Yeoh & Koronios, 2010).  
Proper planning and scoping is necessary to understand the key objectives and how 
the deployment can have optimal impact on those objectives (Attaran & Attaran, 2019). 
This also includes the definition of clear goals, project size, budget, and deadlines. This 
generic success factor ensures flexibility and adaptability and the opportunity to focus on 
crucial milestones (Cresswell et al., 2013; Farzaneh et al., 2018; Gao et al., 2015; Hawk-
ing & Sellitto, 2018; Nemati & Barko, 2003; Saltz & Shamshurin, 2016; Yeoh & Ko-
ronios, 2010). Akhavan & Salehi (2013) add that also a strong evaluation plan must be in 
place which measures the outcomes of the major milestones based on scope creep, budget, 
and time. 
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From the very early stages, effective involvement of stakeholders and clear communi-
cation of the implementation process by the managerial level are crucial (Juciute, 2009; 
Saltz & Shamshurin, 2016; Wamba et al., 2015; Yeoh & Koronios, 2010). Stakeholder 
engagement involves all the activities that are undertaken to involve the stakeholders in 
a positive manner (Greenwood, 2007). The stakeholders in this situation following the 
onion model (Alexander, 2005) are: the users i.e. clinicians (normal operators), the pa-
tients and their families, the board of the hospital (financial and political stakeholders), 
the responsible project management team (functional beneficiary), the developers and/or 
the vendors of the tool (maintenance and operational support), the billing and audit func-
tions, legal regulators, the government, and the related academic community. Hospitals 
should involve all stakeholder in the strategic decision-making process, as this impacts 
the operational level (Malfait et al, 2017). Especially end users must be engaged in order 
to meet their demands and expectations. Moreover, end users know better what is needed 
for successful deployment as they have direct experience with the tool in practice (Yeoh 
& Koronios, 2010). 
Leadership style of the project owner affects the way employees perceive the deploy-
ment process (Øvretveit et al., 2007). Strong clinical leadership contributes to IT adop-
tion because of the creation of a long-term commitment vision, motivation, and the capa-
bility to maintain confidence and stability (Bezemer et al., 2019; Buntin et al., 2011; Inge-
brigtsen et al., 2014). Clinical leadership encapsulates healthcare staff who set, inspire, 
and promote values and vision, using their clinical experience and knowledge to ensure 
patient well being is at the center of organizational goals (Jonas et al., 2010). Clinical 
leaders are thus able to enhance quality and transform clinical services towards excel-
lency. Although generally a strong project management leadership is recognized as criti-
cal (Farzaneh et al., 2018; Goa et al, 2015), clinical leadership is something specific to 
the healthcare industry.   
Strategic alignment includes functional integration between business strategy, BI&A 
strategy, infrastructure, and processes (Williams & Williams, 2010). An aligned vision 
and strategy is a generic factor important to all types of analytics project deployment in 
a company (Akhavan & Salehi, 2013; Gao et al., 2015; Saltz & Shamshurin, 2016). 
Hence, also in hospitals the fit between the strategy in the visioning phase and the pro-
posed BI&A tool must be ensured (Altuwaijri, 2012). A project should only be selected 
for deployment if it matches the long-term vision of the hospital. Big data initiatives are 
driven by the management, therefore a strategic vision must direct the implementation 
and continuation. If the business vision is not well understood, the adoption and outcome 
of the deployment will be affected (Yeoh & Koronios, 2010). Table 9 gives an overview 
of the complete Management perspective. 
57 
 
Table 9 Literature review: the Management perspective 
The ‘Management’ perspective Generic (G) or specific (S)? 
Top management support G 
Planning and scoping G 
Stakeholder engagement G 
Strong clinical leadership S 
Aligned vision and strategy G 
4.2 People 
The human element is critical to IT deployment in healthcare in numerous ways. Both on 
the strategic and operational level, roles and responsibilities have to be clearly defined, 
since a well-defined organizational structure is key for big data projects (Saltz & Sham-
shurin, 2016). Responsibilities must be appointed to people for dealing with changes in 
scope and complexity of the algorithms (Marinos, 2004). Changes in external conditions 
can demand for adjustments of the algorithm. Also, the intricate integration of a predictive 
model into existing clinical workflows must be supervised. The cost of ownership that 
comes with responsibilities of oversight can be a significant barrier for the correct and 
secure employment of predictive tools (Amarasingham et al., 2014).  Ownership is a type 
of responsibility regarding the outcome and quality of the project. This also includes af-
tercare: the monitoring and maintenance of algorithms to guarantee long-term quality. 
Multidisciplinary self-steering teams are required for the success of big data projects 
(Saltz & Shamshurin, 2016). Multidisciplinary teams consist of members with analytical 
and technical skills, as well as clinical experts and a business champion who follows a 
primarily business-centric perspective (Gao et al., 2015). Self-steering teams operate au-
tonomously and have shorter operationalization times due to their self-steering character. 
Yeoh & Koronios (2010) found that BA teams should aim for the so-called “best of both 
worlds”: to be cross-functional and composed of both technical and business employees. 
In the case of hospitals, there is a third group required representing the side of clinical 
medicine. Data scientists and healthcare professionals need to team up in an interprofes-
sional manner, preferably together with patients (Bezemer et al., 2019). 
When employees are committed to the mission and goals of their organization, and 
deem their daily activities truly interesting, their productivity and satisfaction raises. In 
order to see the benefits from health IT such as CPMs, it is crucial to have employee ‘buy-
in’ (Bezemer et al., 2019; Buntin et al., 2011). Buy-in promotes the engagement and will-
ingness to make a new BI&A solutions successful. A higher level of employee involve-
ment in hospitals that go through a technological change, leads to increased performance 
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and the potential to enhance the effectiveness of health IT (Litwin, 2011). Employee com-
mitment in BI&A deployment is multiple times highlighted in literature (Akhavan & 
Salehi, 2013; Farzaneh et al., 2018). Since employee buy-in as a CSF also applies to other 
industries, employee buy-in is a generic factor. 
Another factor that is important in all types of IT deployment plans, is the schooling 
of staff (Saltz & Shamshurin, 2016). Investment in training and education of staff that 
uses the predictive tool is a necessity (Cresswell et al., 2013). Most clinical professionals 
do not have a background in data science, and thus must receive at least a basic course in 
the world of informatics (Krumholz, 2014). Simultaneously, clinicians must be trained 
into a new data mindset that is comfortable with new approaches to medicine. If a user is 
not familiar with the tool, does not understand how it is build, or does not see its benefits, 
the tool will most likely not be utilized the way it was intended. Clinical staff must be 
equipped with the relevant competencies to use predictive tools, for example the ability 
to interpret results appropriately (Wang et al., 2015). Next to that, knowledge sharing 
between users and other clinical staff is important to better understand the CPM and the 
organizational goals. Knowledge can be shared through documentation, learning by 
watching, or teaching one another. Reciprocity, behavioral control, and trust are factors 
that positively affect the knowledge sharing intention of hospital employees (Lee & 
Hong, 2014). 
Top management, project teams, and users need a degree of awareness of recent de-
velopments in the BI&A area (Gao et al., 2015), as well as the related uncertainties and 
risks (Akhavan & Salehi, 2013). For hospitals, new CPMs that are developed in various 
clinical areas are interesting to follow. Often, clinicians are highly specialized in their 
own branch of medicine and follow related developments closely. However, following 
technological developments in other medical areas helps to fully grasp the opportunities 
and limitations of CPMs and to remain critical. Due to the uniqueness of medical data 
that influence (predictive) data mining opportunities (see subsection 2.2.2) this factor is 
quite specific to healthcare. 
Documentation skills are important for successful operationalization of a BI&A tool. 
Employees need a certain degree of awareness for proper documentation. Creating and 
maintaining documentation is vital for the long-term success of a new innovative system 
(Gao et al., 2015). Access to documentation is closely related to knowledge sharing as it 
allows staff to use the expertise of others about the same tool (Farzaneh et al., 2018). 
Continuing on the human element, the issue of patient consent is highlighted. Although 
the deployment of a scientifically stable tool to support clinicians sounds ideal, it is the 
patient who decides whether or not their EHR can be used, and whether or not they want 
to cooperate with a new technology. The Dynamic Consent model is proposed, in which 
patients can tailor their preferences on the extent to which they want to share their data at 
any time (Kaye et al., 2015; Spencer et al. 2016; Williams et al., 2015). In the qualitative 
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research by Spencer et al. (2016), 98% of the participants believe that the altruistic bene-
fits of data sharing outweigh the risks. Traditional consent policies often imply that indi-
vidual control of data outweighs societal benefits of sharing data (Roski et al., 2014). 
Davis (2012) states that in order to harness to potential of big data analytics, a different 
approach towards consent is needed. Rather than strict regulations for each individual 
case, consent should evolve to a balance between personal control and informed sharing 
for the greater good of public healthcare. Patient consent is a challenge that is unique to 
the healthcare industry. 
Furthermore, the impact of the use of the tool on doctor-patient relationship can be a 
more long-term challenge. It must be ensured that at no point in time the shared doctor-
patient decision-making is replaced by a tool (Amarasingham et al., 2014). Clinical diag-
nosis and prognosis depends highly on complex personal factors that cannot be captured 
by a tool, and thus the doctor-patient relationship should always have a leading role 
(Schoenhagen & Mehta, 2016). Trust between doctor and patient is highly important for 
a good-natured treatment. 
Successful teams have collaborative communication. Team members communicate 
frequently, both indirectly and directly, within the multidisciplinary team and with other 
stakeholders (Farzaneh et al., 2018; Saltz & Shamshurin, 2016). Collaborative communi-
cation enables the transfer of expertise and the integration of various individual and func-
tional resources of knowledge. It is therefore a direct antecedent of knowledge sharing. 
Collaborative communication can also be linked to other CSFs. Cresswell et al. (2013) 
state that open channels of communication between users and project management avoids 
scope creep. In a way, all factors are, to some extent, influenced by the communication 
between stakeholders. This is a factor important in any project, in any industry. Table 10 
gives an overview of the People perspective. 
Table 10 Literature review: the People perspective 
The ‘People’ perspective Generic (G) or specific (S)? 
Roles and responsibilities  G 
Multidisciplinary self-steering teams G 
Employee buy-in G 
Education and knowledge sharing G 
Technology development awareness S 
Documentation skills G 
Patient consent S 
Doctor-patient relationship S 
Collaborative communication G 
 
60 
 
4.3 Technology 
In the ‘Technology’ section, the factors surrounding technological components are dis-
cussed. System interoperability between various health platforms can be a challenge to 
many, slightly outdated, IT infrastructures. Patient information often resides in different 
EHR platforms, hence it can be a problem to collect the full data profile of a patient and 
feed it to the predictive model. Issues in system interoperability can slow down the scala-
bility of the tool  (Amarasingham et al., 2014). As long as the storage and dissemination 
of patient data is not a shared effort between multiple platforms, it remains impossible to 
get optimum results from the analysis of that data (Marcheschi, 2017). Data fragmentation 
is one of the major issues in handling clinical data (Lustberg et al., 2017). The issue be-
comes even more enhanced in multicenter studies with data from multiple institutions, 
for example in the case of model validation. Integration of datasets involves the combi-
nation of multiple tables or records in order to create a new dataset. Part of the quality of 
the system of a tool is the ability to integrate data (Gao et al., 2015; Yeoh & Koronios, 
2010). Just access to relevant data sources is not enough, integration of data is needed for 
optimal delivery (Popovič et al., 2018). 
The creation and dissemination of documentation should be a fixed part of a BI&A 
project (Gao et al., 2015; Saltz & Shamshurin, 2016). Document collection and access is 
important to ensure the model can use data from traditional systems, structured IoT data, 
and unstructured data. Data availability and access is at the core of big data developments 
(Demchenko et al., 2013). Also in the deployment phase, the collection and access of data 
is crucial. Since it is only possible to find answers in data when using the right documents, 
document collection and access to sources is a significant problem (Gao et al., 2015). 
Flexibility and scalability of the infrastructure are important to respond to dynamic 
business needs (Cresswell et al., 2013; Yeoh & Koronios, 2010). The IT infrastructure 
should be able to answer quickly to external changes and growth. With a flexible technical 
infrastructure, system expansion is possible according to evolving information needs (Ol-
szak & Ziemba, 2007). Moreover, it becomes easier to adjust to problem situations or 
unexpected changes (Gao et al., 2015). Both user and data capacity should be quickly 
scalable to hospital demand. Table 11 gives an overview of the Technology perspective. 
Table 11 Literature review: the Technology perspective 
The ‘Technology’ perspective Generic (G) or specific (S)? 
Interoperability and integration G 
Document collection and access G 
Flexibility and scalability of  
infrastructure G 
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4.4 Processes 
From the ‘Processes’ point of view, multiple potential obstacles can be found in the liter-
ature. The existence of clear processes for specific goals is an important part of successful 
deployment. 
Data governance is about the responsibilities for a collection of data management 
methods for the acquisition, storage, and aggregation of data (Khatri & Brown, 2010). 
The big data analytics architecture at the organization in question must include some sort 
of data governance layer for data quality management (Saltz & Shamshurin, 2016). This 
layer controls how the data flows through the organization. According to Wang et al. 
(2018), the first component of data governance is the master data management. This en-
tails the proper standardization and cleaning of data in order to create a complete, reliable 
and accurate master data file. This master data file is used for supporting data analysis 
and decision-making. The data lifecycle management is the second component of data 
governance. Here, data is archived, maintained, tested, delivered, and deleted according 
to its position in the life cycle. It is important to manage data effectively over its lifetime 
to be able to respond to internal and external needs and goals.  The third component fo-
cuses on data security and privacy management. Patient privacy is particularly critical in 
healthcare environment as the information is highly sensitive and subject to medical con-
fidentiality. A data governance mechanism is imperative to ensure regulatory and legal 
compliance. In her framework, Philips-Wren (2015) addresses this challenge by looking 
at the strategic, tactical, and operational levels. For the strategic level, the entire big data 
spectrum should be covered by the governance layer. This includes use of the right data 
sources, use of the right technologies, and ensuring the appropriate skills to handle it in 
an informed and timely manner. 
An iterative, standardized methodology is advised throughout the deployment of a new 
BI&A tool (Gao et al., 2015; Yeoh et al., 2010). An iterative approach entails the adoption 
of incremental delivery, with small changes following each other. Short, measurable steps 
are taken over every iteration, which reduces risk. The development methodology of 
BI&A is often a challenging issue, as organizations must make sure that both successes 
and shortcomings are measured (Farzaneh et al., 2018). When an organization tackles a 
BI&A deployment non-iteratively, the risks and impact are harder to manage. At the same 
time, a degree of standardization based on the consensus of different parties helps to max-
imize interoperability and quality. Business process standardization establishes best prac-
tices for carrying out processes related to the deployment of analytical models.  
A proper, user-oriented change management strategy should guide the process of 
change (Cresswell et al., 2013; Saltz & Shamshurin, 2016; Yeoh & Koronios, 2010). The 
layout of multidisciplinary teams must support the ability to respond on the changes (Gao 
et al., 2015). Problems along the way require immediate action and cannot be ignored. 
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Resistance to change accompanied with deploying PA can arise in different shapes. For 
example, Finlay (2014) describes the human vs. machine judgment. Evidence shows that 
field experts do not easily trust predictive models over their own judgement.  
Project evaluation is a generic step in project management and aims to determine the 
level of achievement in terms of objectives, effectiveness, efficiency, impact, and sus-
tainability. For the operational evaluation of a BI&A project, a specific process should be 
in place that is able to measure project outcomes and its algorithms (Akhavan & Salehi, 
2013; Gao et al., 2015). Evaluation metrics of big data projects are often generic, but there 
is no universal metric available (Saeed & Ahmed, 2018). The ability to evaluate a BI&A 
project goes hand in hand with a certain level of clarity of project deliverables (Saltz & 
Shamshurin, 2016). Moreover, evaluation is not a static process. Rather, algorithmic per-
formance should be continuously monitored. If needed, the system should be tuned reg-
ularly to meet operational goals (Gao et al., 2015). Closely related to evaluation is value 
measurement. Whereas evaluation is about continuous monitoring of the algorithmic per-
formance, value measurements focuses on measuring the impact of the project. Value 
measurement registers the realized impact of an analytical tool and is a business respon-
sibility. Another important aspect of evaluation is alignment with the initial goal. In terms 
of CRISP-DM, this implies that phase 1 (business understanding) has a two-way relation-
ship with phase 6 (deployment). A deeper explanation of this is provided in subsections 
2.4.4 and 2.4.5. In the evaluation process it should be assessed whether the model actually 
does what is required from it. In other words, does the way the model is utilized align 
with how it was initially planned to be utilized.  
In the long term, it is a challenge to ensure the sustainability of a BI&A solution. The 
sustainability is largely dependent on other deployment challenges; if these are overcome, 
it is more likely that the tool will live a long life. It is therefore important that during 
implementation and continuation, the long-term goals are kept in mind by means of a 
future roadmap. Moreover, the development of an information sharing, data-driven cul-
ture in the organization is part of the requirements for lasting success (Wang et al., 2018). 
All stakeholders, including the users, payers, vendors and patients, should support and 
advocate the use of CPMs. An overview of all Processes factors is provided in Table 12. 
Table 12 Literature review: the Processes perspective 
The ‘Processes’ perspective Generic (G) or specific (S)? 
Data governance protocol G 
Iterative, standardized methodology G 
Change management G 
Evaluation G 
Sustainability of the tool G 
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4.5 Data 
Lastly, the ‘Data’ perspective takes on issues that are inherent to the data. Patient data 
privacy is an ever growing concern in big data analytics in healthcare. The developer or 
vendor must be able to verify privacy laws and agreements are respected and that sensitive 
information is kept private regardless of internal and external forces (Abouelmehdi et al., 
2018). Cohen et al. (2014) recommend that if the developers have complied with the reg-
ulations on privacy, the patient data can then be freely used for further development with-
out explicit consent. Healthcare data security solutions must be working alongside the 
model to protect sensitive data assets while satisfying healthcare compliance mandates. 
The understandable worries of patients about their data’s secondary use are a challenge 
for adoption and utilization of the CPM if security cannot be guaranteed. 
Transparency of the model could encourage and facilitate cooperation among stake-
holders, thereby increasing trust and diffusion of the CPM (Amarasingham et al., 2014). 
A clinician should be able to take a look into the model in order to compare the logic and 
weighing factors with his or her own assessment. However, objections to full transpar-
ency touch again upon the issue of patient privacy. Therefore, transparency should be 
allowed only to oversight bodies, not to the general public (De Laat, 2018).  
High quality of big data is key to add BI&A value in the organization (Akhavan & 
Salehi, 2013; Farzaneh et al., 2018; Nemati & Barko, 2003; Saltz & Shamshurin, 2016; 
Wamba et al., 2015). The actions resulting from a BI&A project often have significant 
consequences for the organization, which makes it crucial to ensure data quality (Gao et 
al., 2015). Especially in hospitals, where results of a CPM directly affect human wellbe-
ing, data quality cannot be underemphasized. The following five data dimensions all re-
late to data quality: availability, usability, reliability, relevance, and presentation quality 
(Cai & Zhu, 2015). Data availability encompasses the easy accessibility of data in a 
timely manner. Data should be regularly updated with new instances and processed into 
the algorithm. Data usability refers to the challenge of credibility. The source of the data 
must be reliable and coming from specialized organizations. Moreover, the data should 
be checked regularly to assure correctness of the content. Data reliability consists of four 
factors: accuracy, consistency integrity, and completeness. This indicates that data must 
reflect the true state of the information source without any ambiguity. Over a certain time 
period, the data must remain consistent and verifiable. Furthermore, the data format re-
quires a degree of standardization and should be consistent with structural integrity and 
content integrity. Data relevance relates to the fitness of data. The retrieval theme of the 
BI&A goal must match with the information theme. In other words, the collected data 
must clarify the initial problem understanding and goal setting. The presentation quality 
includes readability of the data. Hence, data content and format should be clear and 
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understandable. Also, data description, classification, and coding content are easily com-
prehensible. In Table 13, all factors of the Data perspective are listed. 
Table 13 Literature review: the Data perspective 
The ‘Data’ perspective Generic (G) or specific (S)? 
Patient data privacy S 
Data transparency G 
Data availability G 
Data usability G 
Data reliability G 
Data relevance G 
Data presentation quality G 
 
The practical application of BI&A tools in healthcare make it a unique playground 
(Niaksu, 2015). In Appendix A an overview is provided on each of the deployment factors 
per category, including variable name, description and corresponding literature. Figure 
20 provides an overview of the results from this chapter, with the various factors divided 
over the five categories. This overview serves as the first version of the developed artifact. 
 
Figure 20 Overview of literature review results: first version of artifact 
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5 CONCEPTUAL MODEL: INTERVIEWS 
This chapter answers RQ2, RQ3, RQ4, and RQ5. The literature review of the previous 
chapter is first validated by means of requirements collection interviews (RQ2). Based on 
these interviews, various factors are added, removed, or changed. This results in the de-
velopment of the artifact (RQ3). In the second part of this chapter, the artifact is validated 
by means of expert interviews (RQ4). All factors are discussed with their relative im-
portance to successful deployment according to the interviewees. The chapter concludes 
with new insights on various topics are deducted from the interviews (RQ5). 
 
RQ2 What deployment factors of CPMs in hospitals are identified by health professionals? Chapter 5.1 
RQ3 What artifact can be designed to successfully deploy CPMs in hospitals? Chapter 5.1.4 
RQ4 What are the CSFs in a deployment plan for CPMs in hospitals as identified by health professionals? Chapter 5.2 
RQ5 What other factors have a hand in the successful deployment of CPMs in hospitals according to health professionals? Chapter 5.3 
5.1 Results requirements collection 
During the requirements collection period, four experts were questioned about the find-
ings of the literature review. The literature is validated from a medical, data, and risk 
management angle. The artifact is adjusted accordingly. 
5.1.1 New factors 
Based on the data collected from the requirements collection interviews, new factors are 
added to the model that were not yet identified as such in the literature review.  
In the category ‘Management’ a new factor was added named “clear strategy” (1.1.). 
Two interviewees emphasized the importance of this factor on successful deployment. A 
clear strategy at the management level entails having a clear sense of direction and com-
mitment towards the action plans that were designed for the achievement of the strategic 
goals. If there is no clear strategy with regards to BI&A efforts in the hospital, this affects 
all other factors in the ‘Management’ category directly.  
In the category ‘Technology’ a new factor was added named “user-friendly tool” 
(3.5.). The piece of software on which the prediction model runs must be designed in such 
way that the user intuitively knows how it works. This includes the easy retrieval of 
66 
 
accurate and reliable solutions, as well as simple and intuitive displays, and easy naviga-
tion. Prediction tools can be directive or assistive. Directive tools provide risk-corre-
sponding decision recommendations to the user, whereas assistive tools do not. The for-
mat of the prediction tool should be designed in a way that minimizes any unintended 
effects (Kappen, 2015). 
Next to new factors inside the categories, three general, overarching components are 
added. During the requirements collection, it became clear that three topics are of im-
portance in all categories. “Legal regulations”, “information security”, and “ethics” in-
fluence each category and its factors in various ways. Legal regulations affect people, 
processes, and organizations. Data privacy is one of the biggest issues related to data 
analytics, together with information security. Next to that, there are laws about using soft-
ware as medical supportive device, laws about intellectual property, laws about patient 
involvement, laws about quality of healthcare, etcetera. The legalities surrounding hospi-
tals are extensive and complex. With the arrival of BI&A, these legal regulations need to 
be updated in accordance with the current possibilities and threats. Medical data and sur-
rounding processes need to be secured airtight. This is an ongoing operation: 
“Regulations do not know how to deal with self-learning algorithms. It is 
not possible to validate a self-learning algorithm according to law.” 
“Technology is faster than the legal regulations.” 
Information security refers to the technical and operational measures that ensure data 
is safe and secure. All processes and working aspects inside the organization should ad-
here to appropriate information security levels. Therefore, this needs to be tackled on the 
organizational level. For example, by hiring professional privacy officers, creating aware-
ness under employees, and ensuring appropriate access rights. These efforts should pre-
vent external and internal cyberattacks, such as malware, viruses, and hacking, as well as 
physical, non-electronic security breaches.  
The ethics behind data-driven analytics is another topic that touches all categories in a 
unique way. Who owns medical data? What is the price of data? Should we know when 
our data is used? Next to a legal issue, privacy and consent are also ethical issues. Our 
healthcare system in the Netherlands is based on the solidarity principle. That means that 
citizens pay for other citizens’ healthcare. Does that mean we should also be solidary with 
our data and make it available to improve care for everybody? What is the role of the 
hospital in the big data era in terms of corporate responsibility and compliance? There are 
countless standpoints that play a part in the possible discussions about healthcare ethics 
in the big data era. All of them are potentially challenges to successful deployment of 
CPMs.  
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5.1.2 Removed factors 
In the ‘People’ category, the factor “documentation skills” has been removed due to in-
correct interpretation. Documentation skills were described as the “creation and mainte-
nance of proper documentation regarding deployment of the tool”. In other words, users 
(i.e. health professionals) need to document important activities and errors regarding the 
usage of the tool. However, the way this is formulated implies a substantial increase in 
the administrative workload of the user. This is not underlying meaning of the factor. 
Therefore, this factor is removed. The fact that the users must be aware of the importance 
of proper documentation and data collection, is included in the “education and knowledge 
sharing” factor. For data quality reasons, users must see the value of good documentation. 
Accuracy of predictive models increases when high quality data is used. Thus, when users 
develop a ‘data mindset’, proper documentation skills will follow and become part of the 
workflow. Another way to interpret this factor, is that proper documentation skills leads 
to better monitoring of the performance of the tool. Documentation of the outcomes of 
the tool ensures high performance in the future. This perspective is included in the 
changed factor “durability” (4.4.).  
5.1.3 Changed factors 
Based on the data collected from the requirements collection interviews, multiple factors 
have changed either linguistically or in terms of content. These changes reflect the prac-
tical truth in (academic) hospitals and thus improve the literature review findings.  
 In the category ‘Management’, the factor “aligned vision and strategy” has been re-
placed by “organizational alignment” (1.6.). The reason is that the old factor focused 
solely on vision and strategy, and the link to business objectives. However, this descrip-
tion steers too much towards a business case approach, whereas that is not the desired 
approach to be taken in healthcare innovation projects. 
“Indeed, you need to think about your vision and strategy, and what you 
want to do with predictive models. But there is a difference between doing 
that in order to make clinical care more efficient and optimizing processes, 
or because you want to improve healthcare. (...) Alignment between vision 
and strategy is more important than making it measurable objectively.” 
The current description includes a more complete organizational alignment, focusing 
on alignment between strategy and all types of organizational aspects (e.g. capabilities, 
resources, systems, culture, etc.). This removes the focus on hard numbers of strategic 
alignment with business objectives.  
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    In the category ‘People’, the factor “roles and responsibilities” is exchanged for 
“predefined roles and responsibilities” (2.1.). Roles and responsibilities should not be 
shaped along the way. This creates a risk that team members take on roles that are not 
supposed to be part of their activities.  
“Clear roles should already be defined by the project leader. This avoids 
that a data scientist does the work of the data engineer, or the doctor starts 
to do things that are not part of his or her job. Such as planning meetings.” 
Moreover, when roles and responsibilities are predetermined, the learning capabilities 
of employees can enlarge. When everybody exactly knows what is expected from them, 
a clear, open, and collaborative atmosphere can be created. On the one hand, it allows 
people to address their co-workers in a positive way, for example by asking how that 
person is doing with a certain task or by offering help. On the other hand, a feeling of 
responsibility generates more initiations towards collaboration. Everyone is eager to 
make their part a success, and thus is more likely to want to work together.  
In the same category, the ‘self-steering’ part is removed, establishing the factor “mul-
tidisciplinary teams” (2.2.). Whereas multidisciplinarity of teams was considered as an 
absolute requirement, interviewees indicated that teams should not be self-steering.  
“I do not believe at all in self-steering teams. You have a corporate policy 
with guidelines, and within these borders teams can organize themselves, 
but not steer.” 
When teams are self-steering, there is a risk that, out of enthusiasm, they will steer the 
project towards a wrong direction. A direction that does not follow organizational align-
ment. Thus, instead, teams should be self-organizing, managing responsibilities and time-
lines in accordance with the corporate policy. Another interviewee noted that often steer-
ing within the team goes automatically, as long as roles and responsibilities are predefined 
and there is a clear project strategy and vision. 
The factor of “patient consent” is changed into “patient involvement” (2.6.). The pre-
vious description of patient consent, included two different things: legal consent and vol-
untarily engagement. The legal aspect of patient consent is part of many different legal 
regulations that play a role in the deployment of CPMs. Therefore, it is removed as a 
specific factor, but represented in an overarching component of “legal regulations”. The 
voluntary part of patient consent remains, and is renamed into “patient involvement”. 
This entails the positive attitude and active involvement of a patient regarding the deploy-
ment of CPMs in their situation.  
 
In the category ‘Processes’, the factor “iterative, standardized methodology” is 
changed into “agile and standardized methods”.  The iterative approach to project man-
agement resides inside the agile working methodologies. Therefore, the more broad term 
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of ‘agile’ is used to capture all instruments that are part of the agile process, such as 
scrum, lean, kanban, stand-up meetings, user stories, and retrospectives.  
Another important change has been made to the “sustainability of the tool”. The name 
is changed into “durability”. This term captures much better the underlying meaning of 
the factor. Sustainability can be confused with the need to have a triple bottom line. How-
ever, the intention was to include the long-term view of the prediction model. A durable 
model is a model that is made for success over a long period of time with continuous high 
performance. To achieve this, various processes need to be in place to ensure software 
durability, hardware durability, durable stakeholder support and efforts, and a general 
data-driven culture in the hospital. Moreover, the ‘of the tool’ part is removed. 
“You need to trust the process around to algorithm, not that specific algo-
rithm. You need to be sustainable in the way of working. That also makes 
it easier to maintain stakeholder support.” 
It is less important to have a sustainable tool, compared to having a sustainable way of 
working. Thus, a specific algorithm that is translated into a tool does not necessarily have 
to be durable. Rather, the mission to work with PA for better healthcare must be durable.  
5.1.4 The CRISP-DM Deployment Extension for CPMs 
The artifact, called the CRISP-DM Deployment Extension for CPMs, that is con-
structed after the literature background, literature review and requirements collection in-
terviews is depicted in Figure 21. On the top, on the left hand side, the CRISP-DM is 
positioned. In order to define “success”, the deployment factors must be linked to the 
business understanding phase at the start of the CRISP-DM development model. A two-
way relationship between phase 1 (business understanding) and phase 6 (deployment) is 
added to the existing model. This represents the importance of business understanding for 
the measurement of project success, as explained in subsections 2.4.4 and 2.4.5. The ar-
row pointing from the deployment phase towards the levels 0, 1 and 2 visualizes where 
this thesis research is positioned in the CRISP-DM model. 
The lower part of the artifact is composed of three levels. Level 0 corresponds to the 
goal of this thesis: a successful deployment strategy of CPMs for hospitals. Levels 1 and 
2 correspond to the 5 categories and the 30 deployment factors that are, each to a different 
extent, important to success. To what extent each factor contributes to success according 
to experts, is discussed in section 5.2. Three overarching factors are depicted at the bot-
tom. An overview in table format including descriptions of each factor can be found in 
Appendix C. 
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Figure 21 The CRISP-DM Deployment Extension for CPMs 
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5.2 Results expert interviews: deployment factors 
During the expert interview period, eight experts were questioned about the artifact in 
terms of importance to success. This results in an average level of importance to success 
for each factor, illustrated in 30 small tables. A green-colored circle indicates that the 
majority agrees to high or very high importance. An orange-colored circle indicates in-
termediate importance, and a red-colored circle indicates low or very low importance. 
When there are two circles with different colors, the opinions are substantially dissimilar. 
5.2.1 Management category 
• Clear strategy 
A lot of division exists about the need for a clear strategy hospital-wide. On the one hand, 
it is considered as crucial to widespread success of CPMs, and at the base of all other 
factors. Formulating a clear strategy prior to deployment avoids wandering off to side 
paths that surpass the real goal. On the other hand, a clear strategy is considered as some-
thing that is not necessarily needed, since most initiatives come from bottom-up, and top 
management level is not always involved in these developments. The type of investment 
also makes a difference: if it is a truly pioneering project, it should be part of the strategy. 
That way, it is possible to show stakeholders the advancements in the strategy. 
 
• Top management support 
In general, top management support is considered as important to success. Especially 
from the budget-side, it is required that top management gives room for these type of 
initiatives. However, some argue that even without concrete top management support, the 
intrinsic motivation of employees can make deployment successful from a bottom-up ap-
proach. As long as they do not forbid it and provide some resources, a CPM could be a 
success according to them. Other interviewees go against this by saying that top manage-
ment support should be an ‘all in or nothing’ strategy. Doing it half-way will not lead to 
any positive result. 
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• Planning and scoping 
Planning and scoping is another factor in which there is a division between the opinions 
of interviewees. On the one hand, predetermined phases ensure a project stays within its 
borders. If planning and scoping is not in place, the project will become a loose cannon 
that cannot be controlled. An interviewee notes: 
“The less you agree on before implementation, the lower the chance it will 
succeed. People shape their activities and efforts in accordance with the 
set timeline or budget. It is good to have this clear for everyone.” 
On the other hand, especially professionals working at hospitals fear for an approach 
that is too much like a business case. The value is not necessarily in euros, key perfor-
mance indicators (KPIs) such as a steep learning curve is more important for innovative 
projects than hitting the target budget-wise or time-wise. Moreover, a certain degree of 
flexibility is needed to be able to deal with adjustments along the road. There needs to be 
some room for modification of the planning and scoping according to the deployment 
journey. Moreover, the description of the factor consists of elements with each a different 
level of importance to success. Predefined goals, deadlines, scope, and budget are not all 
evenly important according to the interviewees. 
 
• Stakeholder engagement 
The majority of the interviewees indicated that stakeholder engagement is of moderate to 
high importance. Many different people need to support the deployment of clinical pre-
diction models, from doctors to developers to patients to the government, and more. Good 
stakeholder engagement ensures all visions are taken into account and everyone supports 
the project. The only way to make big data work, is by working together. Within hospitals, 
but also between healthcare organizations. The only note is that stakeholder engagement 
is not necessarily only a task of the higher management, but from all levels. 
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• Strong clinical leadership 
Strong clinical leadership is unanimously supported as a CSF. Firstly, it is critical to have 
a clinician as part of the central team who can determine the added value of an IT invest-
ment for healthcare. The chief medical information officer (CMIO) is the clinical author-
ity involved in IT decisions, but also on lower levels a doctor can show clinical leadership. 
Their medical knowledge is needed to put the data into context and assist with interpre-
tation of the model, problem indication, and patient profiles. Secondly, the clinical leader 
plays a pivotal role in creating a support base. When known critics or leaders support a 
product or tool, they can convince and energize colleagues of the benefits. It is difficult 
to enforce an analytical supportive tool from the management board only. Strong clinical 
leadership and ambassadorship makes the medical staff automatically more supportive. 
 
• Organizational alignment 
The opinions about the importance of organizational alignment for clinical prediction 
projects differed. On the one hand, organizational alignment brings all previous factors 
together, and is seen as a prerequisite for any successful analytics project in hospitals. If 
the deployment is a true pioneering project that makes you a front runner hospital, it is 
important to align the organization in order to strengthen the related strategy and commu-
nication. On the other hand, it is considered as a utopia, something that is practically 
impossible to reach. Hospitals that deploy these models are already a big step ahead of 
the average hospital. To also align the entire organization with the deployment efforts, is 
considered as unrealistic and unfeasible in these early stages. Surely, there needs to be an 
atmosphere that allows for innovation in which CPMs can foster and blossom. However, 
it is not a CSF; without complete organizational alignment, such projects are still expected 
to become successful. 
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5.2.2 People category 
• Predefined roles and responsibilities 
The discussion about roles and responsibilities is whether they should be predefined or 
not. Some interviewees think predefinition is crucial to put the right persons with the right 
tasks. In order to enlarge the learning capabilities of employees, predefined roles and 
responsibilities are important for a clear, open and collaborative atmosphere. This allows 
for positive feedback moments and more teamwork. Next to that, it creates a feeling of 
responsibility that triggers employees to cooperate more in order to reach success. Some 
other interviewees think predefinition is not desirable. Hospitals often do not have the 
appropriate expertise in-house for such projects, which means they might need help from 
external parties. Moreover, roles can change during projects. It is more about the capabil-
ities of the team, than about predefining their roles. When the team is innovation-driven 
and wants to collaborate, roles and responsibilities will get an appropriate division by 
themselves. In reality, people are often capable of taking over a role that might initially 
not be very obvious. There needs to be room for this. Lastly, a remark is made about 
predefined roles that can turn out to be unpleasant. Getting the responsibilities of a less 
popular task is demotivating. Rather, such tasks should be evenly divided, a process that 
often goes naturally in well-performing teams, according to an interviewee. 
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• Multidisciplinary teams 
Multidisciplinary teams is one of the factors that received the highest score for im-
portance. It is an ultimate CSF that teams are an interplay of people that understand (clin-
ical) medicine, people that understand data, software and statistics, and people that un-
derstand the healthcare business. Next to that, the input of the patients is mentioned a few 
times. This will be further discussed in the factor patient involvement and doctor-patient 
relationship. One interviewee mentioned the presence of a psychologist in the multidisci-
plinary team. A psychological perspective ensures the human aspect is represented, and 
that the ultimate tool is reachable for user and patient. It can thus be worthwhile to include 
people with less obvious backgrounds in the team. Some team members are multidisci-
plinary by themselves: they are highly knowledgeable in more than one specific domain. 
In conclusion, all interviewees agree that people with different expertise join forces and 
collaborate in a team in order to successfully deploy CPMs. 
 
 
• Employee buy-in 
Another factor that received the highest score for importance is employee buy-in. Doctors 
and nurses must have a positive attitude towards the tool, otherwise adoption is zero. 
There are many challenges to overtake in this area, since many employees are skeptical. 
A major concern is that more electronic services increase the registration workload. Lev-
els of documentation are already high in healthcare, some simply refuse to let this grow 
higher. Because employees do not always see the value of proper documentation, they 
are sloppy in their documentation which decreases data quality for CPMs. Another con-
cern is that PA touches the professional autonomy and take over or outperform current 
jobs. Employees are rarely enthusiastic about something that automates their job. New 
tools are often perceived as difficult, inferior, and extra workload. It is therefore crucial 
that hospitals work on a change in mindset. In that sense, employee buy-in is highly in-
terdependent with the factor of change management. Good examples from practice in-
crease the number of enthusiastic employees and their willingness to work with CPM. 
Another challenge is to overcome the hesitation in data sharing. Healthcare professionals 
are often reluctant to share ‘their’ valuable database with others, because it is perceived 
as property personally collected. Although it requires serious effort to increase employee 
buy-in, it is definitely a CSF according to the interviewees. A supportive CPM cannot be 
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forced by the upper management, as might be the case with analytical tools in other in-
dustries. It is the doctors and the nurses who decide if the tool is actually used at the 
hospital bed in accordance with its potential.     
 
• Education and knowledge sharing 
Similarly to the issue discussed in the prior factor, the real challenge behind proper edu-
cation and knowledge sharing is the lack of a data mindset. The majority of the interview-
ees agrees that it is critical to transform the vision of healthcare professionals with regards 
to data. Employees must understand that what they insert, directly influences the models 
that can make their work easier. This requires the development of the right knowledge, 
which in turn can change their mindset. Practical examples, creating a common language, 
awareness, and some basic lessons on the core of data modelling is thus essential for 
adoption and deployment of clinical prediction models. Training with the tool is consid-
ered as not important, since the tool should be entirely intuitive to any user. 
 
• Technology development awareness 
The factor that is considered as least critical to success is technology development aware-
ness. Interviewees think it is not needed and simply impossible to demand this awareness 
from all stakeholders. Doctors and nurses are often specialized and very focused on their 
own tiny piece of healthcare. If they do not have a natural interest in technology-related 
topics, that should not be a problem. However, some argue their should be at least a few 
members of each team that do have higher than average knowledge about technological 
developments. An idea is to appoint ambassadors or champions that are responsible for 
following such developments. When working in a multidisciplinary team, the information 
can be easily spread between people with varying functions. 
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• Patient involvement 
Patient involvement is a factor that generated different opinions with regards to the extent 
of the involvement. On the one hand, interviewees argue that patients need to be involved 
to a large extent. First, because this avoids solving problems that are not actually problems 
or the desired solution according to the patient. Second, because patients need to be in-
formed better about the use of their personal data and how it can improve healthcare. 
Third, because every patient is different and requires a different approach. There is no 
such thing as ‘the’ patient, and thus everyone’s personal opinion should be weighed when 
taking the decision to use predictive modeling. On the other hand, some interviewees 
argue that legal consent already implies that the patient has a positive attitude towards the 
tool. Moreover, it is simply not possible to involve the patients in such complex matters 
as predictive modeling. There is a difference in involving the patient in the technical side 
of the tool and involving the patient in the general journey of PA in healthcare. Lastly, 
some interviewees believe in the judgement of the doctor. There is a reason that a doctor 
is treating a patient: they are simply more knowledgeable and experienced in that field. 
With or without the support of predictive models, it is the doctor who reaches a diagnosis 
or prognosis. The patient needs to trust the doctor in this. 
 
• Doctor-patient relationship 
The majority of the interviewees agrees that the doctor-patient relationship is a factor that 
should be considered carefully in order to be successful. However, it remains unclear how 
the doctor-patient relationship will change when there is a CPM involved. One notion is 
that the relationship will become triangular, with an extra player added to the traditional 
doctor-patient dynamics. Another notion is that there already is an invisible third player: 
the protocol. That is what doctors have to follow, and a predictive model will become 
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part of it. This implies it is more about trust of both the doctor and the patient in new 
technologies, rather than a doctor-patient-computer relationship. Another interviewee ar-
gues that a patient does not directly interact with the prediction model, hence there is no 
relationship there. At least not for now, perhaps in the future that will change. Another 
notion is that it is the doctor that uses the tool and who involves the patient with it. The 
tool gives an advice, and the doctor explains this together with own experience and 
knowledge. That would imply a linear relationship, rather than a triangular. Although it 
is unclear how the doctor-patient dynamics will evolve when deploying clinical predic-
tion models, one concept that keeps coming back is trust. There needs to be trust in many 
different things: trust in the computer, trust in the doctor, trust in the algorithm, trust in 
the developer, trust in the system, etcetera. In conclusion, doctor-patient relationship is a 
CSF that needs to be further explored.  
 
• Collaborative communication 
The opinions about the importance of collaborative communication varied. On the one 
hand, collaborative communication was identified as crucial in order to grasp the right 
patterns in data. Clinicians and data scientists need to frequently talk with one another in 
order to get the data in the right context. A common language is one of the most important 
elements of collaborative communication. One interviewee indicates that physical meet-
ings are required in order to create unity of language. Next to communication within 
teams, communication across teams is also important. This leads to cross-pollination: 
problems, ideas, and solutions are shared between teams which causes change. One team 
follows the useful practices of another team. On the other hand, collaborative communi-
cation is less important due to the continuing gap between healthcare and data profession-
als. Although both parties are putting in effort to meet each other in the middle commu-
nication-wise, this gap will always exist. As long as they understand each other’s core 
messages, it is possible to successfully collaborate. Moreover, within hospitals different 
departments often work on their own ‘islands’. The developments on that island are care-
fully communicated, but what happens in other departments is not necessarily of interest 
to the employees. For the deployment of one specific prediction model, this might indeed 
not be necessary. However, when implementing models in multiple departments, hospi-
tals must be wary not to reinvent the wheel over and over again. 
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5.2.3 Technology category 
• Interoperability and integration 
The majority of the interviewees think that interoperability and integration of systems and 
platforms is important to success and poses a true challenge. The healthcare industry is 
currently dominated by two large software companies that provide EHR systems: Epic 
and ChipSoft. Some strongly emphasized the blockage that fragmented information sys-
tems in Dutch healthcare cause. For example, tests need to be redone when a patient 
changes hospital, because the patient data cannot be easily transferred. Others indicated 
that it is important albeit not crucial to success, since CPMs often focus on data within 
one hospital. This will change in the future, when such models roll out more broadly. 
However, not only technological constraints hamper interoperability and integration. Cul-
tural differences and privacy are also issues that arise. 
 
• Data collection and access 
The majority of the interviewees think that data collection and access is important to suc-
cess and poses a challenge to deployment. Data needs to be traceable and accessible. De-
cisions need to be made about how data is accessible, by whom and in what time period. 
The hardware needs to support this, to save and store data and run the algorithm. Data 
harmonization, combining and extracting data is perceived as a frustration. Complex 
workarounds are invented to solve these problems, which makes the process less efficient. 
The importance of proper collection and access of data is emphasized because of the need 
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to recalibrate the prediction model. It is a continuous effort to keep the model up to date, 
which means data needs to be collected and accessed continuously as well. 
 
• Flexibility and scalability of infrastructure 
The majority of the interviewees recognizes flexible and scalable infrastructure as im-
portant to success. The very nature of big data analytics demands high computational 
power. For big user groups, it is therefore a requirement to have the appropriate infra-
structure or to work with a cloud solution. An interviewee points out that especially in 
healthcare the available computer systems are outdated and lack capacity for big data 
solutions. Moreover, when making predictions on human lives it is especially important 
to respond to certain analytical questions quickly, otherwise data is already antiquated. 
The discrepancy is between flexibility and affordability. Outsourcing computational 
power through cloud solutions can provide external tooling to execute advanced analytics. 
 
• User-friendly tool 
The user-friendliness of the front-end tooling is considered as extremely important to 
successful deployment. The user should not experience the prediction model as extra 
workload; it should support their workflow, not hamper it. That means that the tool needs 
to be intuitive and interpretable by anyone. The goal when designing the tool is to get the 
highest possible return with the least amount of clicks. A tool that is not easy to use, will 
not be used. As one of the interviewees stated: 
“A fool with a tool is still a fool” 
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5.2.4 Processes category 
• Data governance protocol 
The majority of the interviewees considered a data governance protocol as important to 
success. The many rules, regulations, and administration create a complex environment 
where a data governance protocol is needed. Especially for scalability of models a proto-
col is important. Although it is possible to still be successful without a data governance 
protocol, it would mean you need to reinvent the wheel every time another clinical pre-
diction project is started. Next to that, one interviewee pointed out the importance of such 
a protocol to be able to reengineer the prediction model. A timestamp of the exact data 
that was inserted in the algorithm is needed to be able to go back to the data that created 
a certain prediction. Healthcare data, such as oxygen levels or blood pressure, changes 
every second, which increases the importance of a data governance protocol that controls 
the data flows. 
 
• Agile and standardized methods 
Interviewees’ definition of ‘agile’ is not aligned. For some, agile means predefined goals 
and deadlines, while for others ‘predefined’ does not match agile thinking. It is also noted 
that in healthcare, methods are often called ‘agile’, but in essence they are not actually 
agile. Agile methods are more familiar to the IT world and the business perspective. Not 
everyone working in hospitals understands what agile working means and it is certainly 
not always part of the way of working. Certainly, opinions about the importance of agile 
methods therefore differ. On the one hand, iterative and small steps adaptable to external 
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change is considered as something only important in the development phase, not in de-
ployment. On the other hand, short cycles with deliverables are also found important dur-
ing implementation and continuation. Some think IT deployment processes are generally 
very standardized, whereas others think it is wrong to treat innovative projects as tradi-
tional projects with standard methods. Moreover, the combination of agile and standard-
ized also caused confusion, since these seem to be contradictory.   
 
• Change management 
The opinions about the importance of change management strongly differ. On the one 
side, it is considered as an extremely important element of successful deployment. The 
entire system needs to be transformed: from patient, to healthcare professional, to man-
agement. This requires a change in the organizational culture, which is often a challenge. 
First, the identification of change is difficult. Second, being open to change, and third, 
adopting change. New data analytics are sometimes perceived as a ‘threat’ against pro-
fessional autonomy. The job is not finished when an algorithm is implemented; from the 
start, all stakeholders need to be identified and benefits need to be clearly explained. In-
terviewees clearly link change management to employee buy-in. These two factors are 
highly interdependent. On the other side, change management is considered as not im-
portant because it is not relevant. A CPM is simply supportive software used in the back-
ground of the consultation. Following that argument, end users should not experience the 
deployment as a big change in their workflow. The healthcare process is not really chang-
ing, rather existing processes are supported in novel ways. 
 
• Evaluation process 
The majority of the interviewees identifies the evaluation processes as critical to success. 
Firstly, because algorithms’ performance needs to be monitored continuously to avoid 
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that it becomes obsolete or useless over time. Secondly, the evaluation process provides 
the evidence that can convince critical professionals of the benefits to healthcare. Thirdly, 
it is a means to deal with errors and breakdowns and improve the model accordingly. 
Fourthly, because it allows you to measure all the time, money, and effort that goes into 
the project and benchmark it against the initial goals. In other words, it allows you to 
measure whether a project is a success and to do honest evaluation of the added value. 
Although documentation for evaluation purposes increases workload, it is broadly con-
sidered as the duty of the developers and users to put in the effort for accurate and com-
plete registration. The evaluation process was often linked to agile methods, because of 
its incorporated feedback loops. A minority considered evaluation processes as less cru-
cial, for the reason that when there is an error, complaints will follow automatically. How-
ever, that is only one of the objectives of the evaluation process. 
 
• Durability 
The factor ‘durability’ requires a partitioning into two areas. The durability of the model 
or tool itself is considered as not important. It is inherent to these models that they are 
connected to new technologies. If a model is designed with the promise of a long-term 
solution, it ignores the constant stream of technological innovations. Thus, the actual so-
lution should by definition be changing in accordance with innovation. The durability of 
the data mindset, the structure behind the solution, is highly important. The mindset needs 
to be one of continuous learning and continuous improvement in order to enlarge the trust 
in the technology. In other words, it is not about trust in one algorithm, but about trust in 
the system that produces algorithms and in the way algorithms work. That creates long-
term trust. Moreover, the right maintenance and service is required to ensure performance 
in the future. Durability is hence often linked with the evaluation process, as this process 
allows for the measuring and steering towards long-term performance. 
84 
 
 
5.2.5 Data category 
• Patient data privacy 
All interviewees scored patient data privacy as extremely important to success. If data 
privacy is not taken into account as CSF for deployment, a project is not likely to succeed. 
All stakeholders, internally and externally, will lose their support. In the development 
phase, data privacy solutions must be initiated, and afterwards it needs to be constantly 
showed and proved that privacy is on the agenda. The data and surrounding processes 
need to be secured airtight, with the help of lawyers and privacy officers. Some critical 
interviewees noted that patient data privacy should not be located at the data level, but 
rather at the organizational level. Indeed, the overarching factor of ‘legal regulations’ and 
‘information security’ captures the privacy issues on a higher level. In this privacy factor 
on the data level, the anonymization of data plays an important role. 
 
• Data transparency 
All interviewees consider data transparency as a CSF for deployment, mainly because it 
is the only way to generate acceptance by end users. Doctors want to know how the results 
from a CPM are constructed, and simply do not accept it if it cannot be explained. How-
ever, this is context-dependent, since in some situations the doctor can simply check if 
the model is right. For example, the detection of a tumor can simply be confirmed. But 
for the prediction of chemotherapy outcome, the doctor certainly wants to know why a 
certain prediction is computed. Next to that, it is important to make a differentiation be-
tween the transparency of the data and the transparency of the algorithm. On a higher 
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level it must be clear how a predictive algorithm works and on what data it is based. 
However, it is not feasible to expect transparency and understanding of the actual code. 
 
• Data availability 
Data availability is generally considered as important, but with the side note that it is 
dependent on the specific model. For example, self-learning models need near real-time 
data, others do not. Also, in some cases it is crucial that the results of the model are de-
livered immediately, in other cases results can come hours later and still be of substantial 
support. However, in general holds: no data, no model. 
 
• Data usability 
In general, the credibility of the data is considered important. Algorithms must be trained 
on expert data, otherwise they cannot be validated. Especially when ‘big data’ is not that 
‘big’, it needs to come from reliable sources. 
 
• Data reliability 
Data reliability is also considered important, albeit with some side notes. Big data is in-
herently not reliable. By definition, data is not complete, consistent, or accurate. If a 
model works only on complete, crystallized data, it will not work in real life. A model 
should be able to deal with a pile of very diverse data in terms of reliability, and make 
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sense out of that. That is very difficult, but necessary for practical application. Also, data 
reliability is getting less important, because of new techniques such as transfer learning. 
Thus, although perfect data reliability cannot be expected, it is important to have data that 
is reliable enough for a model to make sense out of it. 
 
• Data relevance 
Data relevance is another factor that is considered important, but with a big side note. The 
way you approach the data makes a big difference: do you want to solve a specific prob-
lem and then start looking for data, or do you have data and then see what you can do 
with it? With unsupervised learning the output values are initially unknown. Complex 
data mining techniques can find patterns in data that we might consider irrelevant. On the 
other hand, using too much (irrelevant) data increases issues with privacy, security, scala-
bility, and flexibility. Moreover, if the goal is to predict a certain situation, it is very im-
portant that somewhere in the data the answer resides. 
 
• Data presentation quality 
The level of data presentation quality is considered less important compared to the other 
data quality factors. Data that does not have proper presentation quality can still be used, 
albeit the data cleaning will require more effort, time, and budget. An interviewee states: 
“If you are a good data scientist, this shouldn’t really matter. It is part of 
your job.” 
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5.3 Results expert interviews: new insights 
Next to the opinions on the deployment factors, the interviews also provoked comments 
on related topics. This section highlights the most interesting and most quoted topics, and 
aims to provide new insights alongside the developed artifact. Figure 22 shows a word 
cloud generated from all transcripts which gives a look into the words most frequently 
used by interviewees. Next to ‘data’, ‘people’, and ‘tool’ (front-end CPMs) it appears that 
the verbs ‘will’, ‘can’, ‘think’, ‘want’ mostly convey an aspect of future possibilities. 
 
Figure 22 Word cloud of conducted interviews 
5.3.1 Overview of (to be) implemented clinical prediction models 
Each interviewee was asked to tell something about the (to be) implemented projects on 
clinical predictions. In order to provide a general overview of types of prediction models 
in hospitals, Figure 23 lists some of the answers given by interviewees. The figure gives 
a good indication of what is currently topical in practice, and in which medical fields 
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prediction projects prevail. It is important to emphasize that all these examples are in a 
different stage, from non-validated algorithms to tools currently used by doctors. 
 
Figure 23 Overview of (to be) implemented CPMs as reported by interviewees 
5.3.2 Healthcare industry specificities  
Based on existing literature, subsection 2.2.2 explains what makes data mining unique in 
healthcare compared to other sectors. The specificities of the healthcare industry were 
also emphasized by multiple interviewees. Although many parallels exist when it comes 
to deployment challenges of BI&A solutions in different sectors, there surely are some 
characteristics that differentiate the healthcare industry from others. 
The providence of healthcare involves rationality, however, on the patient side 
healthcare is anything but rational. Whereas efficiency is a crucial measure for the prof-
itability of many businesses, it is not most important in healthcare. The role of sentiment 
is critical in how people perceive healthcare. The result is always maximized from a pa-
tient perspective, which often involves emotions rather than logic or rationality. The most 
efficient solution is not always preferred for providing the highest quality of life. Two 
interviewees illustrate this: 
“What makes sense practically or analytically, does not always make 
sense to the patient. (...) You can’t say to a patient: “It is statistically not 
feasible to treat your life-threatening disease”.” 
“Healthcare is a sector that is different from, for example, the financial 
sector, where many predictive models are used. In healthcare, we deal 
with humans and human behavior, which cannot be generalized like finan-
cial data.” 
As touched upon in subsection 2.2.2, the ethical considerations behind data mining 
efforts are specific in healthcare, since the ultimate goal is not business related but ex-
tremely social, personal, and directly affecting someone’s life. Therefore, it could be ar-
gued that the development of predictive models comes with a degree of responsibility. 
When utilizing someone’s data for analytical purposes, the responsibility to make the 
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outcomes available could be considered an ethical obligation. An interviewee mentions 
about data coming from the intensive care unit: 
“I think there is a moral obligation to do something with the data you 
gather from extremely sick patients, when you have created a predictive 
model that works. (...) We must fight to make the model available to pa-
tients. If you don’t do that, you are just calculating things because you like 
it. However, you are using patient data for it. Data of really sick patients, 
of which a lot of them die.”  
The organizational structure inside hospitals is complex. A board of directors is re-
sponsible for the quality, safety and continuity of care by formulating and acting upon 
higher strategies. The supervisory board proactively supervises the board of directors and 
provides critical advice. Next to that, there is often a medical board that organizes itself 
in a medical staff association, and monitors the quality of healthcare from a medical per-
spective. This creates distinct dynamics in the management of healthcare organizations. 
Groups with business and medical perspectives need to cooperate on the strategy, vision, 
and mission of the hospital. This can cause a conflict of interest, since business goals and 
medical goals do not always align. Rather than a CIO who takes the big IT decisions, it 
is a joint effort of the board of directors, supervisory board, the CMIO, and the medical 
staff association.  
Furthermore, next to the organizational specificities in healthcare organizations, there 
are other factors that affect the adoption of IT innovation. The many different stakehold-
ers with each their own agenda, financial challenges, governmental legislations and pub-
lic policy, and the demand of accountability of health innovations all hamper the speed 
of adoption in a way that is different from other industries (Herzlinger, 2006). An inter-
viewee illustrates the problem with varying agendas of stakeholders: 
“Things move slowly in the medical world. We are on top of a huge treas-
ure chest filled with data. However, the realization of stakeholders is not 
always present.” 
Another interviewee highlights why big IT decisions in healthcare involve a different 
dynamics than in the corporate world: 
“In healthcare, professionals are often organized in groups. For example, 
a group of specialists in oncology. Inside these groups there is a culture of 
deliberation with one another, whereas in corporate companies, imple-
mentation comes from top-down initiatives. That is why in healthcare there 
is more discussion; it is more important to look for a consensus.” 
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5.3.3 Data standards for clinical data 
The adoption of standards for clinical data is low, leading to less usable data for predictive 
modeling. For proper statistical analyses, data needs to be in a structured form and with 
an appropriate balance between scope and granularity. In healthcare, communication be-
tween health professionals is key. However, each specialty has its own vocabulary and 
character set, with different meanings in different contexts. That implies that free text is 
semantically not interoperable. The problem of local data dictionaries and missing con-
textual descriptions can be partly solved by following the FAIR principles. Data should 
be findable, accessible, interoperable, and reusable (Wilkinson et al., 2016). One of the 
interviewees provided a real-life example that stresses the importance of data standards. 
Doctors and nurses used over 50 different notations to write down a specific antibiotics 
called Augmentin in the EHR of neonatal care babies (Figure 24). Clinical data standards 
would directly increase data quality and hence the possibilities for clinical prediction 
modelling.  
 
Augmentin 
A Au Aug Augmentin Augmentint Augemntin 
Augemtenin Augemtin Augentin Augm Augmantin Augmenstin 
Augmenti Augmentien Augmetiin Augmentim Augmentin\ Augmentine 
Augmenting Augmentinm Augmentinn Augmentint Augmentn Augmentu 
Augmetin Augmetnin Augmintin Augmmentin Augmnentin Augmnetin 
Augnemtin Augnmentin Auhmentin Aum Aumentin (even more) 
Figure 24 Varying notations of the antibiotics Augmentin in data streams of a neo-
natal care unit.2 
5.3.4 Data context 
Closely linked to the need for clinical data standards, is the importance of a data context. 
Data in itself does not provide much information. It is essential to understand which data 
holds information about the cause of a disease, and which data holds information about 
the consequences. The measured values gain meaning when interpreting them in a certain 
context.  
                                              
2 Source: https://www.mobilehealthcare.nl/syllabus/ 
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An example of what can go wrong when data context is not guaranteed, was provided 
by an interviewee. A group of data scientists had created a prediction model for sepsis. 
When explaining it to the medical staff, the reasoning behind the model was not under-
stood by the medics. It turned out that a wrong table with almost identical data was used 
as input to the model. Due to the wrong interpretation of the data context, the wrong 
patterns were captured. This highlights the importance of collaborative communication 
in multidisciplinary teams. Another example is that of blood sugar levels; they are highly 
dependent on the meals you have recently consumed. A number is not just a number in 
healthcare, it always requires a context. 
5.3.5 Data stewardship 
A fundamental part of clinical research is data stewardship; the long-term sustainable care 
for research data (Jansen et al., 2018). In data stewardship, the FAIR principles are ap-
plied in the long-term, including data management, data archiving, and data reuse. This 
way, all stakeholders are able to benefit from the outcomes of high quality data sharing. 
New knowledge and treatments can be developed from FAIR (findable, accessible, in-
teroperable, and reusable) research data.  
Data stewardship is related to data collection and access. The system in which the data 
resides needs to be easily traceable and accessible in a timely manner. If data is not stored 
accurately, cannot be collected or accessed appropriately, data stewardship is in danger. 
Data stewardship is also related to durability. A durable data-driven mindset can only be 
achieved when there is good data stewardship. 
5.3.6 Automated data governance 
The growth of data initiatives and need for data stewardship calls for better data govern-
ance. The use of CPMs are empowered by making data access easy and intuitive. A data 
governance protocol is one of the factors for deployment. Indeed, thinking about the data, 
building a plan for it, allocating responsibilities, measuring the quality of data, knowing 
what the data means when it is created, are all part of the data governance process. There 
is a need to understand the life story of the data. Automated data governance entails soft-
ware that helps users across an organization agree on how data is used, shared, and pro-
tected. This way, organizations ensure automatically that all departments are using the 
data in a consistent manner. All data sources are located and catalogued, which aids in 
the identification of inappropriate or faulty data sources. An automated data governance 
process can provide controls for data management, but is not the ultimate answer. 
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Employee buy-in and stakeholder engagement are required to make to make data govern-
ance automation software work. 
5.3.7 Privacy and the GDPR 
The legal regulations surrounding privacy were strongly emphasized by multiple inter-
viewees. The General Data Protection Regulation (GDPR) that came into effect in May 
2018 for the entire European Union, changed the regulatory goals for researchers and 
health organizations (European Union, 2016). Awareness of the GDPR rules and compli-
ance goals is important for the success of a clinical prediction project. Especially in a 
large scale clinical setting, the consideration of data protection issues must be on the 
agenda already at the early stage.  
The GDPR protects the individual rights of all citizens, and allows for free and safe 
data sharing. However, the regulations are considered to many as complex, which leads 
to a conservative reality in which actual sharing is rarely accomplished. Next to that, parts 
of the GDPR regulations are not conclusive, leading to grey areas. Scared to break the 
law in such grey areas, organizations tend to stay out of them, leading to more conserva-
tism. The trade-off between protecting privacy and sharing information is out of balance, 
with privacy protection getting the upper hand. This jeopardizes the realization of the 
high promises coming from the exploitation of data. An interviewee notes: 
“We are experiencing some issues with our software provider, whose pre-
diction model requires us to comply to the American data protection reg-
ulation. This plays a big role in the further development of the tool here in 
the Netherlands. That is very unfortunate. I think it is more about the feel-
ing of privacy than actual privacy.” 
The role of privacy and related legislation is substantial. But for some interviewees, a 
critical attitude prevails. All the turmoil surrounding this topic in the past years has given 
privacy a significance that may be overrated. The feeling of privacy and actual privacy 
are not always the same. Another interviewee puts forward the presence of our human 
solidarity as the solution to privacy issues. If the right, concrete questions are asked ac-
companied with a proper explanation of what the data is going to be used for, this might 
make privacy a non-issue. Our solidarity for one another surpasses the need to detain our 
(anonymized) data. Next to that, combining and extracting data is a big frustration. The 
difficulty often resides in consent or privacy. However, is it truly privacy that refrains 
people from data sharing, or do they simply not want to share what is often considered as 
a personal property? An interviewee notes: 
“I think sometimes privacy reasons are used as excuses. Access to data can go 
wrong on multiple dimensions. However, I think the real underlying reason is the 
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ego of people. People think they own their own data and don’t want to share it. 
That undermines the common goal.” 
5.3.8 Missing data 
The presence of missing values is arguably part of data science. A model should not only 
work on complete, crystallized data as this does not represent a real life situation. The 
challenge of a predictive model is to make sense out of a pile of data that is diverse in 
terms of reliability. Nevertheless, it is valuable to look behind the reasons of missing 
values and possibly extract information from that. Two interviewees explain why there 
can be value in missing data: 
“I believe that from the missing data valuable information can be re-
trieved. Calculations that show the difference between an ideal dataset 
and the actual dataset provides metadata which can lead to interesting 
insights.” 
“When a doctor does not write something down, it can mean multiple 
things. Maybe he doesn’t know, maybe it is not observed with the patient, 
or it was simply not written down. Only doctors can explain the meaning 
of missing data.” 
On the other hand, missing data leads to lower statistical precision and can introduce 
bias. A solution to missing data is to impute it: replace empty cells with actual values. 
The goal of imputation is to allow all observations to be used for the analysis, not to add 
new information to the dataset (Van Kuijk et al., 2018). It must be ensured that no bias is 
introduced due to this technique, which depends on the randomness of the missing data.  
5.3.9 Transfer learning 
New techniques make it easier to solve data reliability issues. Reliability is explained in 
terms of accuracy, consistency integrity, and completeness of data. As stated by an inter-
viewee, transfer learning is a technique that enables data scientists to do more with less 
data reliability.  
Transfer learning utilizes the knowledge of a machine learning model that has already 
been trained and applied to a different problem. The knowledge that was learned is ex-
ploited in another dataset with few reliable instances. The known patterns that stem from 
the first model serve as the starting point for the second model. This allows a less reliable 
dataset to build a solid model with comparatively little training data. Moreover, using this 
technique makes running models a lot more time-efficient. Although a certain level of 
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data reliability remains a requirement, transfer learning allows us to do more and more 
with less data. This is an example of a technique, mentioned during the interviews, that 
has a direct effect on the importance of one of the factors on deployment success. The 
rapid developments in the data science field must be carefully followed in order to guar-
antee the CSFs are recent.  
5.3.10 Gartner’s bimodal IT 
The nature of CPM deployment is considered as disruptive and innovative by the majority 
of the interviewees. The implementation and continuation of such models should there-
fore not be treated as a traditional IT project. The effectiveness of a model is usually not 
yet perfectly clear and requires a lot of finetuning. Every use case can serve as a learning 
project to perform better on the next one. In order to better explain this innovative infor-
mation stream, the bimodal IT of Gartner is introduced.  
Bimodal is the “practice of managing two separate but coherent styles of work: one 
focused on predictability and the other on exploration” (Pettey, 2016). These two streams 
are acknowledged as Mode 1 and Mode 2. Mode 1 focuses on exploitation of well-under-
stood, predictable areas, while improving legacy systems in a way that fits modern, digital 
demands. Mode 2 is optimized for areas of uncertainty, which allows it to explore and 
experiment with new problems. The combination of the two modes is essential to create 
bimodal capabilities of an organization. That way, organizations are able to solve today’s 
business problems through continuous re-innovation, whilst also creating tomorrow’s 
possibilities through experimentation with emerging technologies. It is important that IT 
projects with an uncertain character are identified as such, and that the appropriate ap-
proach is used.  
At the same time, it must be noted that from an academic perspective there are some 
critical voices. A consensus on bimodal IT’s content and its implementation approaches 
has not been reached (Horlach et al., 2016). Moreover, it is argued that the bimodal IT 
design is an interim stage in a larger transition, rather than the destination (Haffke et al., 
2017). Keeping in mind these pitfalls, hospitals should carefully look at their IT projects 
and make a clear distinction in terms of uncertainty in order to choose the right approach 
for PA projects.  
5.3.11 The action perspective 
The successful deployment of data science projects can generally be described from a 
model that combines four components. First, data must be accessed and prepared in the 
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data engineering component. Second, the algorithmic models are coded in the data mining 
component. Third, the information that stems from the model is presented with corre-
sponding decision options in the data visualization component. Fourth, the action per-
spective of the created model is highlighted in the data entrepreneurship component. 
Overarching these four components are data strategy, ethics, and legislations. Figure 25 
illustrates this data science approach.  
 
Figure 25 Data science approach with data entrepreneurship (action perspective) 
In the implementation and continuation of a data science project such as a CPM, the 
last component of data entrepreneurship should be as clearly defined as the first three 
components. Whereas these first components are active mostly in the stages before im-
plementation, the data entrepreneurship comes into play later. The term entrepreneurship 
should not be confused with the traditional concept of starting a new business. Rather, it 
is about having an action perspective. This implies that what is predicted has the potential 
or possibility to be actually put into action. Can behaviors or processes actually be 
changed with the outcome of the predictive models? The goal should not to predict some-
thing simply because it is possible to predict something.  
5.3.12 Different perspectives 
Part of the goal of the interviews was to generate a holistic outlook on the conceptual 
model, including viewpoints from medical experts, data experts, and IT experts. Although 
there was a consensus on many points, there were also clear differences in the way these 
functions perceive challenges and CSFs of clinical prediction models.  
The risk management perspective balances the impact versus the likelihood of all risks 
associated with deployment. A project management angle is taken, including benefit re-
alization, investments outcomes, and thinking in terms of a business case. The medical 
perspective is generally resistant towards such an attitude. Thinking in terms of business 
case concepts is not part of their demeanor. The patient is at the core of everything, and 
that should prevail in all activities that are part of their job. The data perspective is also 
intrinsically motivated to ‘do good with data’. However, surely they emphasize the value 
of data in everything they do. For example, data quality is something that data scientists 
96 
 
build on, whereas health professionals might see it as an extra administrative burden. A 
data scientist notes:  
“It seems as if, in the healthcare industry, data is considered a burden, 
rather than an opportunity. There is so much data that is not being used. 
It is considered a registration burden. However, if you start to see that it 
can actually improve quality of healthcare, it becomes an opportunity.” 
The different perspectives from various stakeholders clearly come forward in this re-
search. Especially the disunity between data scientists and medical experts is a challenge 
specific to the healthcare sector that must be addressed when deploying CPMs. 
  
6 CASE STUDY AT A DUTCH HOSPITAL 
This chapter is dedicated to a case study at a Dutch UMC. The goal is to test the developed 
artifact in practice through a gap analysis. Two sets of questionnaires are used to compare 
the baseline objectives in terms of deployment factors with the current status of the de-
ployment factors. The results are depicted in radar charts, and present the practical con-
tribution of this research to future projects. 
 
RQ6 How to test the designed deployment strategy in a case study? Chapter 6 
6.1 Case description 
The Department of Psychiatry of the University Medical Center Utrecht (UMCU) in the 
Netherlands is currently researching a CPM that is able to predict aggressive behavior of 
hospitalized patients. A violence risk assessment detects patients at greatest risk of violent 
incidents, such as verbal and physical aggression against medical staff or other patients. 
The relevant activities related to applied predictive modeling make this department a suit-
able case study subject.  
The prediction model published by Menger et al. (2018) applies both deep learning 
and classical machine learning techniques on textual data from EHRs. Data entered by 
psychiatrists and nurses in the first 24 hours of admission is used to estimate a patient’s 
risk of aggression in the following 30 days. The model is based on a binary classification 
decision that classifies the violence risk as low or high. Performance of the model in terms 
of Area Under Curve (AUC) of the Receiver Operator Curve (ROC) is 0.788. Estimates 
of the AUC provide and indication of the utility of the model and allows for comparison 
between two or more models. The higher the AUC (between 0 and 1), the better a model 
can distinguish between classes. A score of 0.788 implies a very promising CPM based 
on text classification, but a degree of caution remains due to unavoidable overfitting.  
The violence risk model is currently being validated in further research. Simultane-
ously, the UMCU Psychiatry department has established a project team focusing on big 
data innovation. The deployment of the CPM is under investigation, including discussions 
with clinicians, nurses, data scientists, and also patients. 
The team members that are part of the case study have a different expertise and back-
ground. The results are based solely on their opinions, which should be taken into account 
when weighing the conclusions. 
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6.2 Results 
Data is collected through questionnaires with a standardized set of questions about each 
deployment factor. This data collection instrument is able to gather practical, fast outputs 
that can be easily compared. The baseline questionnaire is filled in by a main member of 
the project team, who took a retrospective look on the initial objectives of the project on 
each of the factors. Four members of the project team have filled in a questionnaire about 
the current status of the various factors; to what extent is each factor currently in place in 
the organization. One respondent (CS-03) was not able to fully grasp the current situation 
of the project surrounding technology, processes or data. Due to the limited number of 
answers, this questionnaire was disregarded for the radar charts. The remaining three 
questionnaires contained a few unanswered questions, which led to gaps in some radar 
charts.  
The five main categories are represented in a radar chart. The radar chart starts at the 
core and ascends to its periphery in accordance with the Likert scale from ‘very little 
extent’ to ‘very large extent’. The baseline line (in bold grey) shows the desired situation 
as formulated in the first phase (BU phase of CRISP-DM) of the project. The other lines 
(in orange, yellow, blue) represent the answers of three respondents about the current 
situation of the arrangement of the factors. By comparing the baseline to the current situ-
ation, practical insights are gathered on the progress of the factors. Do the critical success 
factors as determined at the start of the project match the current deployment status? In 
other words: can the project be considered a success? 
6.2.1 Management category 
The radar chart of the Management category shows a relatively high match between base-
line and current situation (Figure 26). Respondents have aligned opinions on the current 
status of most factors, visualized by the larger, multi-colored dots. Organizational align-
ment and planning and scoping need to receive somewhat more attention. Interestingly, 
strong clinical leadership was not highlighted as a major CSF, but does receive a high 
score in the current situation. Top management support is exactly where it is intended to 
be. The factor clear strategy is outperforming compared to the initial goals. All in all, the 
team shows a good performance in the managerial category.  
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Figure 26 Case study results: Management category 
6.2.2 People category 
The initial CSFs for the People category varied: whereas some factors are considered as 
major CSFs, others are less important to success (Figure 27). The major CSFs, multidis-
ciplinary teams, employee buy-in, patient involvement, and doctor-patient relationship, 
all score relatively low in the current situation. This indicates that the project team should 
dedicate extra attention to these factors. Since the project is still in pilot phase, there is 
still ample time to further develop these factors. For example, patients were already in-
volved via focus groups in the modelling phase of the project, albeit in the later stages. In 
the deployment phase this can be further expanded. Technology development awareness 
is less critical to success, but already well developed. About education and knowledge 
sharing a respondent notes that the UMCU has been focusing on predictive analytics for 
a long period of time, which has led to a decent amount of shared knowledge amongst the 
team. Collaborative communication, although not a major CSF, still needs some atten-
tion. A respondent explains that this will be further developed in the future, when more 
teams are dedicated to the deployment of CPMs. Unfortunately, no baseline was given 
for predefined roles and responsibilities, therefore it cannot be compared. 
100 
 
 
Figure 27 Case study results: People category 
6.2.3 Technology category 
In the Technology category there is still much to be gained, as depicted in the radar chart 
(Figure 28). The major CSFs, interoperability and integration and user-friendly tool, are 
not yet sufficiently in place. Both should receive serious attention in the advancement of 
the project. A respondent notes that the technicalities behind integration with the EHRs 
are difficult to realize. The opinions about the user-friendliness of the tool vary. This can 
be explained by the subjectivity of the concept. What one person considers as usable, does 
not necessarily apply to the other. The other two factors, data collection and access and 
flexibility and scalability of infrastructure, are approximately at the status that was envi-
sioned at the start of the project.  
 
Figure 28 Case study results: Technology category 
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6.2.4 Processes category 
The Processes category shows an interesting mismatch in the radar chart (Figure 29). 
Whereas the factors considered as moderate to low importance have outperformed, the 
factors considered as highly important to success have underperformed. Agile and stand-
ardized methods and change management are not the key pillars, but are currently in place 
to a high extent. It is worthwhile for the team to reflect on the made efforts, and whether 
factors have developed automatically or if they have deprived resources that could have 
been allocated differently. A data governance protocol is almost considered as suffi-
ciently in place. However, for durability the team should put forth extra time and effort. 
This observation is not surprising, since the project is still in pilot phase and the develop-
ment of a durable data driven-solution with long-term success is rather future-oriented.  
 
Figure 29 Case study results: Processes category 
6.2.5 Data category 
Virtually all factors in the Data category are considered as CSFs (Figure 30). Most factors 
need to be further developed in order to reach the initial goal. Respondents’ opinions are 
aligned about the current status of the factors. All data factors except data presentation 
quality score lower in their current deployment compared to the baseline. However, the 
differences are not alarmingly high and can be overcome. This means that most factors 
are already in place to a ‘large extent’, but not to a ‘very large extent’. Data transparency 
is the only factor that shows a larger gap. A respondent explains the complexity of trans-
parency and the current efforts to develop an adequate interpretability of the CPM. 
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Figure 30 Case study results: Data category 
6.2.6 Practical advice 
On a practical note, an advice is now given to the case study team on the successful de-
ployment of their violence risk model. 
On the one hand, it is recommended that the team examines the factors that are under-
performing compared to the initial goals. These are the factors: planning and scoping, 
organizational alignment, multidisciplinary teams, employee buy-in, patient involvement, 
doctor-patient relationship, collaborative communication, interoperability and integra-
tion, user-friendly tool, durability, patient data privacy, data transparency, and the data 
quality factors. Possibly, more resources need to be allocated to the further development 
of these factors. Activities can be directed towards the enhancement of these factors to 
ensure they will be successful in the future.  
On the other hand, it is recommended that the team examines the factors that are over-
performing compared to the initial goals. These factors are: clear strategy, strong clinical 
leadership, agile and standardized methods, and change management. It is possible these 
factors receive unnecessary attention that could be diverted to more critical success fac-
tors. It is also possible that these factors are developed automatically or unconsciously, 
without requiring additional resources. In that case, it is good to know that the project is 
outperforming on these factors, which perhaps opens new opportunities to capitalize on 
these factors. A last option is that the factors are actually adequately in place, but that the 
initial objectives do not match the current needs. In that case, it is valuable to recognize 
that the project goals have diverted from the initial targets.  
Moreover, an extra weight can be given to the various factors by taking into account 
the importance levels. The most important CSFs that received unanimous agreement are: 
multidisciplinary teams; employee buy-in, user-friendly tool, patient data privacy, and 
data transparency. All these factors are underperforming, which makes it worthwhile to 
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devote extra attention to these factors in the near future. For example, the team can try to 
trace back why these factors are not yet adequately in place, and what measures can be 
taken to change that. It is recommended that these factors are handled with priority.  
Lastly, due to time constraints, the case study is performed with a retrospective analy-
sis on the BU phase. For future projects, the importance of the BU phase should be em-
phasized. The objectives and project plan should directly link to the deployment objec-
tives. This new link between the first and last phase of the CRISP-DM is key to successful 
deployment of CPMs. 
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7 DISCUSSION 
The last chapter sums up the conclusions of this research. An answer to the problem state-
ment is provided, as well as the practical and theoretical contribution. A list of recom-
mendations sets out the determinants for successful deployment of CPMs. Lastly, the 
limitations and directions for future research are formulated. 
7.1 Conclusions 
The goal of this research is to give direction to (academic) hospitals on the factors they 
should bear in mind when planning the deployment of a clinical prediction model. The 
outcomes of this research are directed towards clinicians and hospitals in a practical sense, 
but also to the academic community as further research is required.  
The literature review has identified deployment factors from relevant prior studies. 
The interviews have improved this initial model into the final artifact. The factors multi-
disciplinary teams, employee buy-in, user-friendly tool, patient data privacy, and data 
transparency received remarkably high levels of importance by the majority.  
Consensus prevails on the importance to deployment success on the factors: stake-
holder engagement, strong clinical leadership, education and knowledge sharing, doctor-
patient relationship, interoperability and integration, data collection and access, flexibil-
ity and scalability of infrastructure, data governance protocol, evaluation process, data 
availability, data usability, and data reliability.  
A consensus was reached on the intermediate importance of the factors: top manage-
ment support, organizational alignment, and data presentation quality.  
The majority agreed that the factor technology development awareness and predefined 
roles and responsibilities is of low importance to success. Sometimes the opinions dif-
fered substantially, hence no consensus was reached on the factors: clear strategy, plan-
ning and scoping, patient involvement, collaborative communication, agile and standard-
ized methods, change management, durability, and data relevance. Table 14 provides an 
overview of the level of importance to success of all deployment factors according to the 
interviewees.  
The factors that were identified as specific to the healthcare industry in the literature 
review (chapter 4) do not follow any particular pattern in terms of importance to success-
ful deployment. The specific factors are spread out over different importance levels. 
The practical functionality of the CRISP-DM Deployment Extension for CPMs is 
tested through a gap analysis in the case study. A practical advice is provided to UMCU. 
The effectiveness of the approach requires further research.   
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Table 14 Level of importance to success of deployment factor 
Level of importance 
Extremely high High Intermediate Low No consensus 
▸Multidisciplinary teams 
▸Employee buy-in  
▸User-friendly tool  
▸Patient data privacy* 
▸Data transparency 
▸Stakeholder engagement  
▸Strong clinical leadership* 
▸Education and knowledge  
sharing 
▸Doctor-patient relationship* 
▸Interoperability and  
integration 
▸Data collection and access 
▸Flexibility and scalability of 
 infrastructure 
▸Data governance protocol 
▸Evaluation process 
▸Data availability 
▸Data usability 
▸Data reliability 
▸Top management support 
▸Organizational alignment 
▸Data presentation quality 
▸Technology development  
awareness* 
▸Predefined roles and re-
sponsibilities 
▸Clear strategy 
▸Planning and scoping  
▸Patient involvement* 
▸Collaborative  
communication 
▸Agile and standardized  
methods 
▸Change management 
▸Durability 
▸Data relevance 
Factors with an asterix (*) are identified as specific to the healthcare sector in the literature review 
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Moreover, new insights are gathered next to the deployment factors. An important 
characteristic that differentiates the healthcare industry from others is the interplay be-
tween rationality and sentiment. Moreover, the organizational structure inside hospitals 
is complex. Various stakeholders each have their own agenda, there are financial chal-
lenges, governmental legislations, and the demand of accountability of health innova-
tions. This hampers the speed of adoption in a way that is different from other industries 
The GDPR changed the regulatory goals for researchers and health organizations. Es-
pecially in a large scale clinical setting, the consideration of data protection issues must 
be on the agenda already at the early stage.  
Data context is essential in the healthcare industry. In medicine, each specialty has its 
own vocabulary, with different meanings in different contexts. Even a missing value can 
have meaning in a certain context. Due to the low adoption of clinical data standards the 
amount of usable data decreases. Therefore, data stewardship should be an integral part 
of clinical research efforts. The growth of data initiatives also calls for better data gov-
ernance. Automated data governance is a novel technique that helps organizations ensure 
all departments use data in a consistent manner. Other new techniques, such as transfer 
learning, make it easier to solve data reliability issues. Transfer learning utilizes the 
knowledge of a machine learning model that has already been trained and applied to a 
different problem.  
Innovative projects such as CPMs are generally considered as disruptive, and thus re-
quire a non-traditional approach. The bimodal IT of Gartner is an example of how to 
tackle such projects. Organizations should pay specific attention to the last step of a data 
science project, to ensure data entrepreneurship. This action perspective helps to bring 
the prediction model into practice.  
Lastly, the different perspectives from stakeholders clearly come forward in this re-
search. Especially the disunity between data scientists and medical experts is a challenge 
that must be addressed when deploying CPMs. 
7.1.1 Answer to the problem statement: deployment strategy 
“How to design a successful deployment strategy  
for clinical prediction models in hospitals?” 
 
This research has designed an artifact called the CRISP-DM Deployment Extension for 
CPMs. In combination with the table on importance levels for each deployment factor 
(Table 14), a deployment strategy can be formulated.  
Hospitals that want to engage in CPMs can follow a strategy similar to the one demon-
strated in the case study. At the start of the project, in the BU phase, the project objectives 
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should be determined by following the various deployment factors. When the CPM is 
going into the deployment phase, the various deployment factors should be measured 
again through the opinions of various stakeholders. This way, a gap analysis is able to 
compare the desired status with the current status, and the project can be more efficiently 
and effectively steered towards success. Moreover, the importance level of the factors 
plays a role in weighing the significance and determining resource allocation.  
In conclusion, a combination of the CRISP-DM Deployment Extension for CPMs and 
the importance levels of deployment factors provide a hospital the necessary determinants 
for a successful deployment strategy for clinical prediction models.  
7.1.2 Practical contribution 
This research provides a direct practical contribution through the answer of the problem 
statement. Hospitals are presented with a means to tackle CPM deployment through the 
CRISP-DM Deployment Extension for CPMs and the various importance levels of the 
factors. Following the deployment strategy, determinants for successful CPM deployment 
come forward. As illustrated in the case study, a gap analysis compares the baseline ob-
jectives with the current status. Additionally, new insights offer a look into the minds of 
an array of CPM experts. These insights can be taken into account alongside the deploy-
ment strategy.    
By including visions and experiences from professionals in the medical field and data 
science field, this thesis connects two worlds that are simultaneously different in their 
approaches, but similar in their ambitions. Both groups look at the challenges and oppor-
tunities of clinical prediction models through a different lens. Nonetheless, the common 
end goal is to improve the quality of care, and that common aspiration is at the heart of 
successful deployment of clinical prediction models. 
7.1.3 Theoretical contribution 
In terms of theoretical contribution, this thesis has covered an academic area that is 
scarcely researched. Next to a review of the existing literature, this study contributes by 
providing a new conceptual model that can be further researched. In fact, each of the 
identified factors in itself can be the basis for a new topic in future research. 
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7.2 Recommendations 
Based on the findings of this research, a set of recommendations for (academic) hospitals 
is established. These are the determinants (in no particular order) for successful deploy-
ment of clinical prediction models: 
1. Realize that everything starts at the business understanding phase. The choices 
and outcomes of the first step in the CRISP-DM model affect all other phases. 
Since the output of the BU phase produces objectives and a project plan, it is 
inevitably linked to deployment. This new link within CRISP-DM is a crucial 
one when aiming for successful deployment of CPMs.  
2. Determine what “success” means. When is a deployment successful? What is 
a CSF? These questions need to be answered at the very start of the project, in 
the business understanding phase. Traditional project triangles are nowadays 
extended beyond simple budget, time, and scope constraints.  
3. Use the CRISP-DM Deployment Extension for CPMs. One way to tackle the 
formulation of success, is by following the various factors in this model. Make 
sure that the project team considers all deployment factors and overarching 
factors when working on a CPM project.  
4. Consider the factors’ different levels of importance to success. Whereas some 
factors are considered as highly important to success by an expert panel, others 
are considered as less important. Take this into account when developing the 
objectives, in order to allocate resources appropriately and effectively manage 
expectations of a project.  
5. Follow a deployment strategy. Determine project objectives of the deployment 
factors at the BU phase, and compare them during the deployment phase 
through a gap analysis. Comparison of where a project currently is and where 
it should go allows for more efficient and effective steering towards success.  
6. Take into account other challenges next to the deployment factors. For exam-
ple, healthcare industry specificities, the need for data context and data stand-
ards, data stewardship, and automated data governance.  
7. Do not underestimate the overarching effect that legal regulations (such as the 
GDPR), information security, and ethical considerations have on the successful 
deployment of CPMs. 
8. Have an action perspective. It is easy to get distracted by all the barriers sur-
rounding deployment of CPMs. Although it is necessary to solve these issues, 
they should not become the ultimate goal. In the end, the objective is to im-
prove healthcare for patients through clinical prediction models that are de-
ployed in our practical reality.  
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7.3 Limitations 
In this section, the limitations of this thesis research are acknowledged. The problem 
statement and methodology were critically chosen and linked to relevant literature. How-
ever, whilst discovering new knowledge and conflating existing knowledge, various char-
acteristics of the study design have impacted the interpretation of the findings.  
Firstly, the recognized literature gap on deployment challenges for predictive models 
in the healthcare industry implies a lack of prior research on the exact topic. Prior studies 
focus on parts of the problem statement, which allowed for laying a foundation for un-
derstanding the research areas in their individual forms. However, there is little research 
available that combines prediction models with clinical settings and critical success fac-
tors for deployment. This made it impossible to compare the results to prior studies with 
similar or different methodologies and results. 
Secondly, access to people and organizations was achieved through web searches and 
open invitations. Since not all organizations that work on the deployment of CPMs pub-
lish their efforts online, it was not possible to approach all relevant organizations. The 
pool of interviewees is therefore limited by those who were traceable online and who 
agreed to a meeting. This limited access created an imperfect group of respondents, but 
did not hamper the continuity of the study. However, it should be emphasized that the 
conclusions and recommendations of this study are based on the opinions of this imper-
fect group of interviewees, and can therefore not be considered as the absolute truth. The 
same holds for the group of employees that are part of the case study. More specific to 
the case study, a limitation is that the number of hospitals that are experimenting with 
CPMs is scarce. Therefore, it was not possible to find an organization that is already in 
the deployment phase. The gap analysis is therefore an interim control in this research. 
Moreover, due to the timespan of CPM projects, it was not possible to conduct the base-
line interview at the start of the project. Although the respondent was able to think back 
to this period in time, there is some bias in retrospective answers. These limitations are 
important to acknowledge, as they have a direct impact on the quality of the case study. 
Thirdly, the qualitative nature of the study generated some limitations. Respondent 
bias stems from interviewees that answer to questions based on personal notion of what 
is socially acceptable or desired, rather than their honest opinion. In this research that 
questions the level of importance, interviewees might tend to regard everything as im-
portant, as a socially acceptable answer. Moreover, self-reported data may contain 
sources of bias such as selective memory, telescoping (i.e. temporal displacement of 
events), attribution, and exaggeration. Researcher bias stems from the behavior of the 
interviewer. Although this bias was reduced by remaining as neutral as possible during 
the interviews, the personal characteristics of the researcher always play a role. The varied 
perspectives from interviewees are analyzed based on the limited understanding of the 
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researcher, and different conclusions might be derived by a different researcher. Another 
limitation of the qualitative interviews is that it is not possible to acquire exact result 
verification, as the provided data is not quantifiable and cannot be checked. Similarly, it 
would be a challenge to repeat the research, since it is inseparably intertwined with the 
interviewer and the interviewees. This complicates confirmation or contradiction of the 
original research.  
Fourthly, there are some constraints on the generalizability of the results. This study 
focuses solely on the Dutch healthcare industry, and can hence not be automatically ap-
plied to other countries. The same applies for the type of healthcare organization; this 
study focuses only on (academic) hospitals. Due to the labor intensive approach of qual-
itative data analysis, the scope of the study is limited to one case study. The validation of 
the artifact is therefore based on a single case study, which also hinders the generaliza-
bility to wider populations. 
7.4 Future research 
The limitations of this study are an opportunity for the suggestion of future research. The 
application of a more robust methodology with a set of respondents that is more repre-
sentative of all experts in the research area of a specific country might address the prob-
lem statement more effectively in a future study. Moreover, the study can be expanded 
by following a multiple case study that allows cross-case analysis. The organizations 
should be questioned in the initial planning phases as well as in the deployment phase, in 
order to guarantee objective comparison between deployment factors. Future case studies 
can include a larger amount of answered questionnaires, to increase the possible Likert-
scale calculations and statistical significance. Furthermore, future research can aim to de-
termine a sequence of which factors should receive attention at which point in time. This 
way, the practical contribution for hospitals will become even more concrete. When more 
literature is available on the specific topic, the literature review should be revised to check 
if there are any factors that have not yet been included in the conceptual model. All in all, 
this thesis research has provided a better focus on the future directions of the unanswered 
questions of this research topic.  
7.4.1 From predictive to prescriptive analytics 
According to Gartner (2016), the step after predictive analytics is prescriptive analytics. 
Whereas predictive analytics answers the question of what will happen in the future, pre-
scriptive analytics takes it even one step further. In this field of data mining, the 
112 
 
underlying question is: ‘what should I do to make that happen?’ (Delen & Demirkan, 
2013). This means that prescriptive analytics include the actions required to optimize an 
outcome, rather than just the outcome. It is not just about seeing the future, but also about 
shaping the future. With humans as the core of the objective that requires optimization, 
the application of prescriptive analytics in healthcare is complex (Sappelli et al., 2017). 
The range of options and possible actions are much more extensive and less predictable 
than a physical system. Moreover, the problems of heterogeneous data and patient privacy 
concerns are major slowdowns to prescriptive tools, even to a higher extent than predic-
tive tools. It is expected that implementation and continuation barriers of such future 
models will be similar to the ones mentioned in this thesis. However, the level of im-
portance and severities for success might shift due to the added complexity. When pre-
scriptive tools make their entree in the medical world, further research into the deploy-
ment factors is required to find out to what extent there is an overlap with the outcomes 
of this thesis.  
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APPENDICES 
Appendix A: Literature review in table format 
 
  
Deployment 
factor 
Variable 
name 
Generic 
or spe-
cific 
Description Literature 
1 
Man-
age-
ment 
1.1 
Top manage-
ment support 
M_TMS G Consistent support and sponsorship of top-level execu-
tives for the deployment 
Akhavan & Salehi, 2013; Gao et al. 2015; Hawking & 
Sellitto, 2010; Popovič et al., 2018; Saltz & Shamshu-
rin, 2016; Wamba et al., 2015; Yeoh & Koronios, 2010 
1.2 
Planning and 
scoping 
M_PS G Pre-defined goals, deadlines, scope, and budget Akhavan & Salehi,  2013; Attaran & Attaran, 2019; 
Cresswell et al., 2013; Farzaneh et al., 2018; Gao et al., 
2015; Hawking & Sellitto, 2018; Nemati & Barko, 
2003; Saltz & Shamshurin, 2016; Yeoh & Koronios, 
2010 
1.3 
Stakeholder en-
gagement 
M_SE G Effective involvement and clear communication by the 
management level with all stakeholders 
Greenwood, 2007;  Juciute, 2009; Saltz & Shamshurin, 
2016; Wamba et al., 2015; Yeoh & Koronios, 2010; 
Malfait et al, 2017 
1.4 
Strong clinical 
leadership 
M_SL S A leader who ensures long-term commitment, vision, 
motivation, and stability by using their clinical experi-
ence and knowledge to ensure patient well-being is at the 
center 
Bezemer et al., 2019; Buntin et al., 2011; Farzaneh et 
al., 2018; Goa et al, 2015; Ingebrigtsen et al., 2014; Jo-
nas et al., 2010; Øvretveit et al., 2007 
1.5 
Aligned vision 
and strategy 
M_AVS G Clear link between business objectives, vision and strate-
gies 
Akhavan & Salehi, 2013; Altuwaijri, 2012; Gao et al., 
2015; Saltz & Shamshurin, 2016; Williams & Williams, 
2010; Yeoh & Koronios, 2010 
2 
People 2.1 
Roles and re-
sponsibilities 
Pe_RR G The specific tasks or duties that members are expected to 
complete as a function of their roles 
Amarasingham et al., 2014; Marinos, 2004; Saltz & 
Shamshurin, 2016 
128 
 
2.2 
Multidiscipli-
nary self-steer-
ing teams 
Pe_MST G A mix of team members with analytical, statistical, and 
technical skills, clinical experts, and a business champion 
Bezemer et al., 2019; Farzaneh et al., 2018; Gao et al., 
2015; Hawking & Sellitto, 2010; Saltz & Shamshurin, 
2016; Yeoh & Koronios, 2010 
2.3 Employee buy-in 
Pe_EB G Engagement and willingness of employees; positive atti-
tude of employees 
Akhavan & Salehi, 2013; Bezemer et al., 2019; Buntin 
et al., 2011; Litwin, 2011; Farzaneh et al., 2018 
2.4 
Education and 
knowledge 
sharing 
Pe_EKS G Training with the tool; creating a data mindset; 
knowledge expansion 
Cresswell et al., 2013; Krumholz, 2014; Lee & Hong, 
2014; Saltz & Shamshurin, 2016; Wang et al., 2015 
2.5 
Technology de-
velopment 
awareness 
Pe_TDA S Knowing what is happening in the field of (medical) 
BI&A 
Akhavan & Salehi, 2013; Farzaneh et al., 2018; Gao et 
al., 2015 
2.6 Documentation skills 
Pe_DS G Creation and maintenance of proper documentation re-
garding deployment of the tool 
Gao et al., 2015 
2.7 Patient consent Pe_PC S Approval of patient; positive attitude of patient Davis, 2012; Kaye et al., 2015; Roski et al., (2014); Spencer et al. (2016); Williams et al., 2015 
2.8 Doctor-patient relationship 
Pe_DPR S Shared doctor-patient decision-making; personal engage-
ments; trust 
Amarasingham et al., 2014; Schoenhagen & Mehta, 
2016 
2.9 Collaborative communication 
Pe_CC G Frequent, valuable communication between and across 
teams 
Cresswell et al., 2013; Farzaneh et al., 2018; Saltz & 
Shamshurin, 2016 
3 
Tech-
nology 
3.1 
Interoperability 
and Integration 
T_II G Data sharing between platforms; system compatibility Amarasingham et al., 2014; Gao et al., 2015; Mar-
cheschi, 2017; Popovič et al., 2018; Yeoh & Koronios, 
2010 
3.2 
Documentation 
collection and 
access 
T_DCA G Enabling access to various data sources to collect the rel-
evant documentation 
Demchenko et al., 2013; Goa et al., 2015; Saltz & 
Shamshurin, 2016 
3.3 
Flexibility and 
scalability of 
infrastructure 
T_FSI G The capability of the system to respond quickly to exter-
nal changes and growth 
Cresswell et al., 2013; Gao et al., 2015; Olszak & 
Ziemba, 2007; Yeoh & Koronios, 2010 
129 
 
4 
Pro-
cesses 
4.1 
Data govern-
ance protocol 
Pr_DGP G Control data flows (master data management, data lifecy-
cle management, data privacy and security); ensure regu-
latory and legal compliance 
Khatri & Brown, Saltz & Shamshurin, 2016; Philips-
Wren, 2015; Wang et al., 2018  
4.2 
Iterative, stand-
ardized  
methodology 
Pr_ISM G Incremental delivery of short, measurable steps in the de-
ployment process 
Farzaneh et al., 2018; Gao et al., 2015;  Yeoh et al., 
2010 
4.3 
Change man-
agement 
Pr_CM G Processes to prepare, equip, and support individuals to 
successfully adopt change 
Cresswell et al., 2013; Finlay, 2014; Gao et al., 2015; 
Saltz & Shamshurin, 2016; Yeoh & Koronios, 2010 
4.4 
Evaluation Pr_E G Measuring the level of achievement in terms operational 
benchmarks; value measurement; initial goal alignment 
Akhavan & Salehi, 2013; Gao et al., 2015; Saeed & Ah-
med, 2018; Saltz & Shamshurin, 2016 
4.5 Sustainability of the tool 
Pr_ST G Long-term success; support by stakeholders; data-driven 
culture 
Wang et al., 2018 
5 
Data 5.1 
Patient 
data  privacy 
D_PDP S Compliance with privacy regulations; healthcare data se-
curity solutions 
Abouelmehdi et al., 2018; Cohen et al., 2014 
5.2 Data  transparency 
D_DT G Ability to take a look into the prediction model Amarasingham et al., 2014; De Laat, 2018 
5.3 
Data  
availability 
D_DA G Easy accessibility of data in a timely manner 
(Part of data quality) 
Akhavan & Salehi, 2013; Cai & Zhu, 2015; Farzaneh et 
al., 2018; Nemati & Barko, 2003; 
Saltz & Shamshurin, 2016; Wamba et al., 2015 
5.4 
Data usability D_DU G Data credibility; data coming from reliable sources; data 
audits 
(Part of data quality) 
Akhavan & Salehi, 2013; Cai & Zhu, 2015; Farzaneh et 
al., 2018; Nemati & Barko, 2003; 
Saltz & Shamshurin, 2016; Wamba et al., 2015 
5.5 
Data reliability D_DRy G Accuracy, consistency integrity, and completeness of 
data 
(Part of data quality) 
Akhavan & Salehi, 2013; Cai & Zhu, 2015; Farzaneh et 
al., 2018; Nemati & Barko, 2003; 
Saltz & Shamshurin, 2016; Wamba et al., 2015 
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5.6 
Data relevance D_DRe G Collected data clarifies the initial problem understanding 
and goal setting; fitness of data 
(Part of data quality) 
Akhavan & Salehi, 2013; Cai & Zhu, 2015; Farzaneh et 
al., 2018; Nemati & Barko, 2003; 
Saltz & Shamshurin, 2016; Wamba et al., 2015 
5.7 
Data presenta-
tion quality 
D_DPQ G Readability of data; content, format, description, classifi-
cation is comprehensible 
(Part of data quality) 
Akhavan & Salehi, 2013; Cai & Zhu, 2015; Farzaneh et 
al., 2018; Nemati & Barko, 2003; 
Saltz & Shamshurin, 2016; Wamba et al., 2015 
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Appendix B: Requirements collection interview questions 
Project: “How to design a successful deployment strategy for clinical prediction models” 
 
Date:........................................... 
Time:.......................................... 
Location:.................................... 
Codified participant:................ 
Interviewer: Stefanie Creemers 
 
Dear participant, 
 
Thank you for taking the time for participating in this interview. This interview is part of the thesis research 
for the International Master in Management in IT (IMMIT), a joint program of IAE Aix-Marseille Université, 
University of Turku, and Tilburg University. The research is conducted in collaboration with BDO Nederland. 
 
The aim of this interview is to discuss the implementation and continuation challenges of clinical prediction 
models in healthcare. Predictive analytics use extremely large datasets and computational algorithms to dis-
cover patterns. Based on data from the past, these patterns can predict with reasonable accuracy what will 
happen in the future. In the case of healthcare, the data coming from electronic health records provide a great 
source for predictive modeling. For example, algorithms can predict the chance of developing genetic colorec-
tal cancer (Drost et al., 2018). Other health sources can also serve as an input to predictive models; for example 
for predicting the progression of dementia based on MRI scans (Korolev et al., 2016). 
Academic literature agrees that these opportunities have a high promise and can improve patient care. How-
ever, it seems that we are stuck at the promise. Research on actual implementation is scarce. Therefore, this 
thesis aims to design a deployment strategy for successful predictive tools in healthcare. In order to design that 
strategy, various deployment challenges are deducted from existing literature and tested through these inter-
views. Based on opinions and experiences from experts in the areas of health analytics, predictive modeling 
and data-driven diagnosis and prognosis, the deployment challenges are rated based on importance for success 
and relative severities.  
Ultimately, the outcomes of this research can provide a direction to healthcare organizations by clarifying 
which challenges deserve more attention and against which challenges they must hedge.  
 
This interview is conducted for a requirements collection. The goal is to validate and adjust the identified 
deployment challenges based on a practical point of view. The interview will consist of two phases. First, an 
open discussion is started to hear the deployment challenges recognized in practice by the interviewee. Second, 
semi-structured interview questions will assess the findings of the theory development. 
 
All information will be handled confidentially and will be processed anonymously in the thesis. The research 
is not connected to patient files, hence patient privacy is not an issue. If desired, outcomes of the study can be 
shared with you or your organization.  
 
If you agree, the interview will be audio-recorded for transcription purposes.  
 
Introduction 
1. What is your official function? How would you describe your profession? 
2. In what way are you professionally connected to big data analytics or predictive analytics? 
3. For how long have you been professionally connected to big data analytics or predictive analytics? 
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PHASE 1: Open discussion 
4. Tell me about your engagement in the development or implementation of predictive tools in your 
hospital. 
5. Are these predictive tools also focused on medical diagnosis or prognosis? 
6. Tell me about some of the challenges you have faced or expect to face with regards to the deploy-
ment of predictive tools. 
 
PHASE 2: Semi-structured questions 
7. I would like to present to you 29 deployment challenges for clinical prediction models. For each of 
these challenges I would like to know your opinion on their importance for successful implementation.  
If you do not have actual experience with clinical prediction models, please think of the hypothetical situa-
tion in case it would be implemented in your hospital. 
Please indicate for every factor whether they are part of the deployment challenges according to you and pro-
vide some explanation. 
 
*** Appendix A: Literature review is handed out to interviewee *** 
 
    Guiding questions (in case not answered clearly yet) 
8. Which challenges are, in your opinion, most important for hospitals to keep in mind? Why? 
9. Which challenges are, in your opinion, least important for hospitals to keep in mind? Why? 
10. Are there any factors that can be removed from this list? Why? 
11. What are your thoughts on the five categories? Do some factors belong in other categories? 
12. Are there any factors that are missing on this list? Why should they be added? 
13. Are there any factors that require a different description? More extensive, less extensive? 
14. What are your thoughts on the categorization of ‘generic vs specific’? Are there any changes re-
quired? 
 
Wrap-up 
15. Is there anything you would like to add? Are there any tips for my research? 
16. Do you want the outcomes of the study to be shared when they are published? If yes, on which email 
address?  
 
Thank you again for your participation in this interview. If desired, the interview report can be shared before 
it is used for further analysis. Once accepted, the anonymized report will be included in the multiple case study 
and cross-case analysis. The final thesis will be published by the three universities, presented for BDO Neder-
land, and can be shared with your organization.  
 
Best regards, 
Stefanie Creemers 
 
Drost, M., Tiersma, Y., Thompson, B. A., Frederiksen, J. H., Keijzers, G., Glubb, D., ... & Boucher, K. M. (2018). A functional assay–based procedure 
to classify mismatch repair gene variants in Lynch syndrome. Genetics in Medicine, 1. 
Korolev, I. O., Symonds, L. L., Bozoki, A. C., & Alzheimer's Disease Neuroimaging Initiative. (2016). Predicting progression from mild cognitive 
impairment to Alzheimer's dementia using clinical, MRI, and plasma biomarkers via probabilistic pattern classification. PloS one, 11(2), e0138866. 
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Appendix C: Artifact in table format after requirement collection interviews 
Level 1 Level 2 Level 3 
Category Factor Description 
Manage-
ment 
1.1. Clear strategy 
  
A clear sense of direction and commitment to the action 
plans that achieve the strategic goals 
1.2. Top management  
support 
Consistent support and sponsorship of the board of direc-
tors for the deployment 
1.3. Planning and scoping Predefined goals, deadlines, scope, and budget 
1.4. Stakeholder  
engagement 
Effective involvement and clear communication by the 
management level with all stakeholders 
1.5. Strong clinical 
 leadership 
A leader who ensures long-term commitment, vision, mo-
tivation, and stability by using their clinical experience 
and knowledge to ensure patient well-being is at the center 
1.6. Organizational  
alignment 
The alignment of all organizational aspects (capabilities, 
resources, systems, culture, etc.) with the realization of the 
strategy 
People 2.1. Predefined roles and 
responsibilities 
The predefined, specific tasks or duties that members are 
expected to complete as a function of their roles 
2.2. Multidisciplinary 
teams 
A mix of team members with analytical, statistical, and 
technical skills, clinical experts, and a business champion 
2.3. Employee buy-in Engagement and willingness of employees; positive atti-
tude of employees 
2.4. Education and 
knowledge sharing 
Training with the tool; creating a data mindset; creating a 
common language; knowledge expansion; digital skills of 
the users 
2.5. Technology develop-
ment awareness 
Employees knowing what is happening in the field of 
(medical) BI&A 
2.6. Patient involvement Positive attitude of patient; active involvement of patient 
2.7. Doctor-patient rela-
tionship 
Trust; shared doctor-patient decision-making; personal en-
gagements 
2.8. Collaborative  
communication 
Frequent, valuable communication between and across 
teams; creating a common language 
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Technol-
ogy 
3.1. Interoperability and in-
tegration 
Data sharing between platforms; system compatibility; 
data fragmentation 
3.2. Data collection  
and access 
Enabling access to various data sources to collect the rele-
vant documentation 
3.3. Flexibility and  
scalability of infrastructure 
The capability of the system to respond quickly to external 
changes and growth 
3.4. User-friendly tool Easy retrieval of accurate, reliable solutions; simple and 
intuitive displays; easy navigation 
Pro-
cesses 
4.1. Data governance  
protocol 
Control data flows (master data management, data lifecy-
cle management, data privacy and security); ensure regu-
latory and legal compliance 
4.2. Agile and standardized 
methods 
Incremental delivery of short, measurable steps in the de-
ployment process 
4.3. Change management Processes to prepare, equip, and support individuals to 
successfully adopt change 
4.4. Evaluation process Measuring the level of achievement in terms operational 
benchmarks; documentation by users; value measurement; 
initial goal alignment 
4.5. Durability Long-term success; continuous high performance; support 
and effort by stakeholders; data-driven culture 
Data 5.1. Patient data privacy Compliance with privacy regulations; healthcare data se-
curity solutions 
5.2. Data transparency Ability to take a look into the ‘black box’ prediction model 
5.3. Data availability Easy accessibility of data in a timely manner. (Part of data 
quality) 
5.4. Data usability Data credibility; data coming from reliable sources; data 
audits. (Part of data quality) 
5.5. Data reliability Accuracy, consistency integrity, and completeness of data. 
(Part of data quality) 
5.6. Data relevance Collected data clarifies the initial problem understanding 
and goal setting; fitness of data. (Part of data quality) 
5.7. Data presentation  
quality 
Readability of data; content, format, description, classifi-
cation is comprehensible. (Part of data quality) 
 
 
